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The development of an HIV vaccine is a foremost universal health priority, necessitating 
research with human volunteers. It has been internationally accepted that informed consent is 
a fundamental ethical requirement for all clinical trials, including HIV vaccine trials (HVTs). 
However prospective trial participants often demonstrate a lack of understanding of 
information conveyed to them during the informed consent process. Ways of communicating 
complex concepts may need to be identified and developed to promote understanding. This 
study had the following aims: (a) To explore communication strategies reportedly 
implemented by key HIV vaccine trial stakeholders to communicate key concepts (Community 
Advisory Board or CAB members, Educators, Consent Counsellors) b) To explore 
correspondence between reported strategies and recommendations from the conceptual and 
empirical literature, and c) To explore the implications for strengthening informed consent for 
research in resource- constrained settings.  
 
The study comprised an analysis of four Focus Group Discussions with key stakeholders at an 
HIV vaccine trial site in South Africa, that had been previously conducted by members of the 
HIV AIDS Vaccines Ethics Group from the University of KwaZulu-Natal (UKZN). These 
stakeholders included CAB members who interacted with participating-community members; 
Educators who interacted with interested community members at the site, and Consent 
Counsellors who interacted with persons interested in enrolment in actual HIV vaccine trials.  
These transcripts were analysed using Thematic Analysis, informed by aspects of a popular 
framework for the informing process (the Meerwein model). This study adopted a qualitative 
approach which was broadly set in an interpretive perspective – focusing on practices, subjective 
meanings that stakeholders attached to their practices, and the context. 
 
Study findings are presented under three main themes. The informational theme describes 
how site staff reportedly employed numerous strategies to ensure that information presented 
to potential participants was understandable, such as simplifying, using preferred language, 
using analogies, using culturally appropriate terms and promoting discussion. The emotional 
theme describes how site staff implemented several strategies to try respond to emotions of 
anxiety and to try address feelings of suspicion, such inquiring about and collating suspicions, 
using trustworthy sources (ex-participants or influential community members) and referring to 
safe, licensed vaccines. The relational theme describes how site-staff reportedly employed 
various practices to develop respectful relationships (by creating a friendly environment) that 
are responsive to cultural norms, such as requesting permission to break cultural norms, and 
using culturally acceptable terms.  
 
The study concludes that strategies employed appear consistent with several key principles 
of adult learning, and communication, as well as with ethical guideline recommendations for 
HIV vaccine trials. These findings imply that the individual consent process is best understood 
as embedded in a larger process of engagement and that consent staff at sites need to have 
core communicative competencies, need to be sensitive to the emotional aspects of their 
engagements, and need to be culturally competent. Recommendations are made for key 
stakeholders such as Research Ethics Committees, CAB members, and ethical guideline 
developers. Recommendations are made to strengthen the informed consent process for 
research in resource-limited settings.  
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1.1  INTRODUCTION AND RATIONALE FOR THE STUDY 
 
Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) is 
still a major health problem in the world. Since the beginning of the epidemic, almost 78 million 
people have been infected with HIV, and about 39 million people have died (World Health 
Organization (WHO), 2015). By the end of 2013, 35.0 million people globally were living with 
HIV (WHO, 2015). In 2012, HIV accounted for an estimated 1.6 million deaths (AVERT, 2015). 
However, the burden of the epidemic continues to vary considerably between countries and 
regions. Sub-Saharan Africa is the worst region affected by HIV/AIDS, and is home to nearly 25 
million people living with the disease, representing 70 % of the global HIV burden (UNAIDS, 
2013). South Africa (SA) has the highest and most high-profile HIV epidemic in the world, with 
an estimate of 6.1 million people living with HIV in a population of 48 million (AVERT, 2015). 
Even though a large Anti-Retroviral Therapy (ART) programme has been largely rolled out, HIV 
prevalence remains high at 17.9 % (AVERT, 2015). Even though ART has proven to reduce HIV 
mortality and has changed the face of HIV, several limitations of these regimens have 
emerged. These include poor daily adherence which may result in drug resistance (Siegel & El-
Sadr, 2006), drug toxicities, and adverse drug reactions like inflammation (Lundgren, 2015).  
 
The most promising way to impact the epidemic is to develop HIV prevention modalities, 
including effective HIV vaccines (Baeten & Celum, 2012; Myers & Mayer, 2011; Poynten, 
Zablotska & Grulich, 2012). The need for an HIV vaccine is paramount and remains a foremost 
universal public-health priority (Kim, Rerks-Ngarm & Excler, 2010). The successful 
development of effective HIV vaccines is expected to require that various  candidate vaccines 
be investigated  concurrently in diverse populations in many settings (UNAIDS, 2012). There 
are many ethical challenges which arise within the context of HIV vaccine trials (HVTs) 
(Lindegger et al., 2006; Macklin, 2009). These include that participating communities and 
participants may have certain vulnerabilities such as being drawn from settings with limited 
resources and power relative to sponsors (Slack et al, 2004), with inadequate healthcare 
systems (Glickman et al., 2009), with inadequate knowledge about research or low literacy 
levels (Glickman et al., 2009; Ndebele, Wassenaar, Munalula & Masiye, 2012). Participating 
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community members and potential participants may also be drawn from settings with cultural 
norms that are not shared by members of the sponsor or researcher team (Glickman et al., 
2009).  
 
It is internationally accepted that informed consent is a fundamental ethical requirement for 
all clinical trials, including HVTs. Consent to participation in HVTs requires that prospective 
participants are fully informed about key components of trial participation, and demonstrate 
comprehension of concepts and their implications (UNAIDS/AVAC, 2011; UNAIDS, 2012). 
Prospective participants often show a lack of understanding of key research concepts in clinical 
trials generally (Flory & Emanuel, 2004) including potential participants for HIV vaccine trials 
specifically (Koblin et al., 2010; Murphy et al., 2007). Poor comprehension of HIV vaccine trial 
concepts may result from numerous challenges including that medical terminology may not 
necessarily translate appropriately into the language used by potential participants, that 
potential participants may have low educational attainment or low scientific literacy and that 
concepts are complex (Lindegger, Quayle & Ndlovu, 2007; Stuurman, 2004; Watermeyer & 
Penn, 2008).  
 
Accordingly, it has been argued that ways of communicating complex research concepts in 
various cultural and linguistic contexts may need to be identified and developed to promote 
understanding (Glickman et al., 2009; Rautenbach, Lindegger, Slack, Wallace & Newman, 
2015), and other positive outcomes, in such trials. An emphasis on how complex concepts are 
communicated in interpersonal consent-related encounters is very important, alongside 
efforts to improve the length and readability of consent forms (Rautenbach et al., 2015). There 
has been little research exploring the communication practices implemented by key vaccine 
trial stakeholders to promote understanding in such trials (Penn & Evans, 2008; Rautenbach et 
al., 2015). This is despite the fact the key ethical guidelines recommend attention to such 
processes – for example to the communication of risks (Medical Research Council South Africa 
(MRC), 2003; Department of Health (DoH), 2004). One way to enhance the comprehension of 
prospective participants in HVTs might be to explore the practices of site-staff communicating 
such concepts to potential participants or participating community members. This might 
inform recommendations for stakeholders involved in such work currently, and inform 





1.2  AIMS OF THE STUDY 
 
This study is an exploration of practices reportedly used to communicate complex concepts in 
HVTs. The key objectives are:  
1. To explore strategies reportedly used by key site stakeholders in South African HVTs 
to communicate trial information 
2. To explore the correspondence of reported strategies with recommended practices 
from the conceptual and empirical literature  
3. To explore the implications for strengthening the informed consent process in 
resource-constrained settings.  
 
 1.3 OUTLINE OF THE DISSERTATION 
 
This dissertation takes the following form:  
Chapter 2 - Literature review: This chapter briefly reviews the HIV epidemic, and the need for 
HIV interventions, including HIV vaccines, necessitating the conduct of HVTs. It reviews the 
need for informed consent in such trials, and complexities with achieving understanding in 
consent. It reviews certain empirical studies in consent. It sets out the need for sound 
communication in consent. It briefly reviews theories of adult education and health 
communication and their usefulness in strengthening consent communication. It also reviews 
the issue of engaging with the participating community to try to strengthen consent processes. 
 
Chapter 3 - Aims and methods: This chapter provides a description of how the research was 
conducted, including how the data was collected, and analysed, and measures which were 
implemented to ensure reliability, validity and rigour. It also describes the limitations of the 
study. It also provides a brief account of the researchers’ consent experiences in Malawi, as a 
commitment to reflexivity. 
 
Chapter 4 - Research findings: This chapter set outs the main findings of the study, including 
major themes and subthemes to shed light on the strategies used by key stakeholders to 
communicate concepts to participants and participating-community members.  
 





Chapter 6 - Conclusions and recommendations: This chapter draws conclusions in relation to 
the main study aims, including the degree to which reported strategies correspond with 
recommendations from the literature. It sets out implications for strengthening informed 
consent for research in resource-constrained settings, and provides recommendations for key 







2.1  INTRODUCTION 
 
This chapter reviews the HIV epidemic and the need for HIV interventions. It describes the need 
for trials of experimental HIV prevention products, such as HIV vaccines. It further reviews the 
need for informed consent (IC) in such research, including strategies that promote sound 
consent communication and processes. It sets out empirical research on strategies that have 
been reported to enhance comprehension in both HIV vaccine trials and other studies. Ethical 
guidelines that govern the consent process in bio-medical research are discussed and 
benchmarks that govern the ethical conduct of research with human subjects. It reviews 
complexities regarding understanding in consent. Lastly, it provides the justification for 
conducting the research.  
 
2.2 THE HIV EPIDEMIC 
 
HIV and AIDS continues to impact the public health of citizens globally, and AIDS is responsible 
for almost 40 million deaths in the world (WHO, 2015). By the end of 2013, 35.0 million people 
globally were living with HIV (WHO, 2015). In 2012 the epidemic accounted for an estimated 
1.6 million deaths (AVERT, 2015). It is estimated that 2.3 million new HIV infections occurred 
globally in 2012, representing a 33 % decline from 2011 (UNAIDS, 2013). The burden of the 
epidemic remains to fluctuate significantly between countries and regions, with Sub-Saharan 
Africa home to nearly 25 million people living with the disease, representing 70% of the global 
HIV burden (UNAIDS, 2013).  
 
South Africa has the largest HIV epidemic in Sub-Saharan Africa and worldwide (AVERT, 2015). 
In 2014, 6.4 million people were HIV-infected, representing 12.2 % of the South African 
population (UNAIDS, 2014).. Although the epidemic in South Africa is generalised, it has been 
reported that specific groups within the general population have HIV prevalence that is above 
the national average. These are classified as crucial populations with high risk of HIV exposure 
(UNAIDS, 2014). Examples of key populations and their prevalence rates include: adults aged 
15-49 with estimated HIV prevalence at 18.9 % (UNAIDS, 2014) and Men who have Sex with 
Men (MSM) accounting for 9.2% of new infections (AVERT, 2015) and sex workers with 34-69 
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% HIV prevalence (AVERT, 2015). The HIV incidence rate in South Africa remains the worst in 
the world with over 400,000 new infections reportedly occurring in 2012 (Shisana et al., 2014). 
Other Sub Saharan countries are also affected. For example, Malawi is among the ten countries 
in the world with the highest HIV prevalence (UNAIDS, 2013). In 2014 an estimated 1,100, 000 
people were living with HIV in a total population of 15.9 million (UNAIDS, 2014).  
 
The expansion of HIV interventions globally has changed both the HIV epidemic and the 
broader public health landscape (UNAIDS, 2013). In 2012, the total number of people receiving 
Anti-Retroviral Therapy (ART) was reported at more than 9 million (UNAIDS, 2013). Vast 
advances in HIV/AIDS treatment regimens have essentially transformed the natural history of 
the disease and have sharply reduced the number of people who die from HIV-related diseases 
in countries where treatment is accessible (Bertozzi et al., 2006). South Africa has the largest 
ART programme globally (WHO, 2015). By 2012, South Africa provided ART to an estimated 2 
million people, exceeding its national universal access target of 80% (AVERT, 2015). Other 
countries in Sub-Saharan African have also implemented responses. For example, Malawi is 
one of the few countries in Sub Saharan Africa with a successful ART service-delivery 
programme (Harries, Makombe, Libamba & Schouten, 2011). Malawi accelerated its ART 
national coverage in 2004 and ART coverage increased from 54 to 67 % between 2010 and 2011 
(AVERT, 2015). 
 
2.3 THE NEED FOR HIV RESEARCH, INCLUDING HIV VACCINE TRIALS 
 
Even though ART has been proven to reduce HIV mortality, methods to prevent HIV infection 
in the first place will likely have a major impact on the epidemic. Much effort has been 
channelled to reducing HIV transmission (Bunnell, Mermin & De Cock, 2006). South Africa has 
scaled up effort to reduce HIV infections by implementing the following HIV prevention 
strategies: PMTCT, PEP, social and behaviour-change campaigns, voluntary testing and 
counselling, integration of sexual and reproductive health services, condom use and 
distribution, and HIV awareness and education (South Africa National Strategic Plan 2012-2016, 
2011). In many Sub-Saharan countries, there are several prevention modalities that are 
currently in use to prevent HIV (cf. National AIDS Comission, 2011). 
 
Despite available prevention tools, it is also important to continue to research new modalities 
to prevent HIV acquisition (Essack, 2014). Current efforts include demonstration projects for 
Pre-Exposure Prophylaxis (PrEP) in gel or pill form which has been shown in clinical trials to 
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reduce the risk of acquiring HIV infection (Beyrer, Bekker, Pozniak & Barré-Sinoussi, 2015; 
McCormack et al., 2015; McGowan, 2014 ). It is recognized that the best way to eradicate a 
global viral epidemic is to systematically immunize target populations with an effective 
prophylactic vaccine (Baeten & Celum, 2012; Myers & Mayer, 2011; Poynten et al, 2012). Efforts 
are underway worldwide to develop and test HIV vaccines in human participants. The 
development process for vaccines is very rigorous, and demanding (Pharmaceutical Research 
and Manufacturers of America (PhRMA), 2013). Due to volatility of the biological micro-
organisms required to produce vaccines, and due to ambiguity about how the human immune 
system will process and respond to the vaccine antigen, one of out ten candidate vaccines will 
achieve licensure (PhRMA, 2013). A candidate vaccine has to undergo clinical trials before 
licensure and trials take place in various phases. Figure 1 below outlines the vaccine 
development process and timelines required for each phase (Training and Resources in 











Figure 1: Vaccine development phases and time lines (TRREE Module, 2014) 
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more than 30 candidate vaccines have been conducted (Esparza 2014). Several phase III trials 
have been concluded with some still ongoing (Esparza, 2014) and one due to be implemented 
in November 2016 (Cathy Slack, personal communication, 15 August 2016). The phase III trial 
of the RV144 vaccine candidate showed an estimated 31.2% efficacy of a vaccine regimen 
against HIV type 1 (HIV-1) and brought hope that vaccines can reduce the risk of HIV exposure 
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many candidates be studied at the same time in diverse populations around the world (Weidle, 
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Even though Sub-Saharan Africa is the most hit region with HIV, there have been few phase I 
HIV vaccine trials (HVTs) (Nam-aidsmap, 2015). Several commentators have underscored the 
need for HIV vaccine development in Africa, and urged that HVTs are needed to assess the 
efficacy and safety of vaccines among its diverse populations (Weidle et al., 2002). South Africa 
continues to be a leading country in Africa in the conduct of preventive HVTs. The country has 
recently conducted a phase I study of the RV144 vaccine tested in Thailand to ensure it was 
safe and tolerable to South Africans (National Institutes of Health (NIH), 2015). Other Sub-
Saharan countries have also been the focus of HIV vaccine trial activity. For example, Malawi 
was poised to test an HIV vaccine – a phase 1 trial with 20 participants (HIV vaccine tests in 
Malawi for UNC project, 2015), unfortunately the trial never received a favourable review from 
The National Health Sciences Research Ethics Committee in that country.  
 
HVTs are ethically complex for a number of reasons. These include that they tend to involve 
communities and participants drawn from host countries with limited resources or power 
relative to partners in high-income countries (Slack et al., 2004). HVTs have invasive 
procedures with potential risks and burdens for enrolled participants. These include: repeated 
HIV testing and counselling, lengthy trial duration that may result in participation fatigue, 
vaccine administration which carries the risk of the preventive misconception (which may see 
participants engage in risky behaviour because they expect to be immune to HIV from the 
vaccine itself), and the risk of Vaccine Induced Seropositivity (VISP) whereby a person who has 
received a vaccine may test positive for HIV on routine tests, regardless of  not actually being 
infected with the virus (which requires differential testing to be distinguished from a true HIV 
infection) (Milford, Barsdorf & Kafaar, 2007; Newman, Seiden, Roberts & Duan, 2009; Allen et 
al., 2001, as cited in Milford et al2007; Jenkins et al., 2005, as cited in Milford et al., 2007). Trial 
procedures may be stressful (Slack et al., 2000; Tarimo et al., 2014) Social harms are possible, 
for example, stigma and discrimination against participants as well as negative reactions from 
friends, family and co-workers or disturbance of relationships (Milford, et al, 2007).  
 
To address the ethical challenges, UNAIDS developed ethical guidelines for the conduct of 
HVTs in 2000 which were later updated in 2012 (UNAIDS, 2012). Also, much research has taken 
place to explore and respond to ethical-legal concerns in such trials. For example, in South 
Africa, the South African AIDS Vaccine Initiative (SAAVI) was established in 2000, which 
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included the HIV Vaccine Ethics Group (HAVEG) that conducts research to address ethical and 
legal complexities in HVTs.  
 
2.4 THE NEED FOR ETHICAL PROTECTIONS FOR PARTICIPANTS  
 
It has long been recognized that collaborative research being conducted in low-resource-
settings (LRS) is critical but requires careful attention to address ethical challenges (Butendeli, 
2011). Challenges include: differences in the education, social and economic standing of the 
participants versus sponsor-investigators and inadequate health-care (Glickman et al., 2009). 
Participants may lack knowledge about research, and trial concepts are likely to be difficult to 
understand (Glickman et al., 2009; Ndebele et al., 2012). Scientific language may not be 
familiar to those with low literacy levels, e.g., double blinding, randomization and placebo 
(Ndebele et al., 2012). Some participants may be vulnerable – that is have some features that 
increase their risk of research-related harms, or features that compromise their ability to give 
consent which may require special steps to ensure that they make sound decisions about 
enrolment (Kruger, Ndebele & Horn, n.d.; MacQueen et al., 2015). 
 
A number of guidelines have been written to ensure that research conducted in these setting 
has ethical merit, and promotes the safety and welfare of participants; these include the 
Belmont Report (Zucker, 2014). Key ethical principles to safeguard the rights and welfare of 
human volunteers in research include beneficence, justice and autonomy (Council for 
International Organizations for Medical Sciences (CIOMS), 2002; World Medical Association, 
2013; Zucker, 2014). These principles attempt to safeguard the dignity, integrity, self-rule, 
privacy, and other rights of research participants, and set out the obligations and 
responsibilities of researchers. Principles include:  
 
o Respect for autonomy: The principle asserts that research participants’ ‟capacity for 
self-determination be treated with respect” (National Commission, 1979, p.19). 
Participants should be treated as autonomous agents and their choices be respected. 
By exercising their autonomy, persons may be protected from risks anticipated in 
research and are fully informed by being given significant information about the 
research. 
o Beneficence: “Do good” and non-maleficence (“do no harm”) underscore the 
obligations of researchers to ensure that anticipated benefits are realised and 
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anticipated risks are minimized (Beauchamp & Childress, 2012). These principles go 
beyond researcher respect for participants’ choices to ensure that the research itself 
promotes ‘good’, and establishes strategies to offset risks (Helsinki, 2013).  
o Justice: This principle stipulates that there be fair distribution of benefits and risks in 
research and if there is unequal treatment it be justified. Researchers must ensure that 
research subjects have been selected equitably (Helsinki, 2013). 
 
A popular framework has been developed to evaluate the ethical and scientific merit of 
research projects setting out key ethical standards for research (Emanuel, Wendler & Grady, 
2000) and key benchmarks for research in LRS (Emanuel, Wendler, Killen & Grady, 2004). 
These standards are: collaborative partnership including that the research is responsive to local 
health needs, social value whereby the study should address a valuable question for the 
economic, socio-political and health context, scientific validity whereby the design is rigorous 
to realise results, fair selection of participants whereby participants are selected for sound 
scientific reasons and to reduce risks, favourable risk-benefit ratio including that anticipated 
risks are mitigated, on-going respect for recruited participants and study communities 
including feedback of research findings to all stakeholders, independent ethics review whereby 
an independent board reviews the initial application and regular study reports, and of most 
relevance to this study - informed consent – discussed in more detail below. 
 
Key ethical bodies that are charged with reviewing the scientific and ethical merit of trials 
include Research Ethics Committees (RECs) (Kruger et al., 2014). RECs play a key role in 
safeguarding the ethical standards and scientific merit of research with human participants 
(Gelling, 1999) expected by society (CIOMS, 2002). RECs must ensure that the rights of 
research participants have been protected (Kruger et al., 2014). This includes ensuring that 
individuals are given adequate information, which can be easily understood (CIOMS, 2002). 
RECs should also attend to the interests of the community who will be affected by the research 
(Gelling, 1999). 
 
Despite increasing attention to ethical standards and mechanisms in research, cases of 
unethical research are still recorded (Butendeli, 2011). For example, in Malawi a trial was 
conducted for which – reportedly - no ethical and regulatory approval for the study drug was 
obtained, several deaths were recorded, and consent was inadequate (Mkoka, 2008). It has 
been asserted that researchers capitalise on research participants’ inadequate knowledge of 
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research and inadequate care in poor or low income countries (Macklin, 2009; Voo et al., 2008, 
as cited in Butendeli, 2011). Others assert that researchers fail to anticipate or merely observe 
associated harm that may occur to research participants and fail to do enough to prevent such 
harms (Benatar, 2004).  
 
2.5 INFORMED CONSENT AS A KEY ETHICAL PROTECTION 
 
Informed consent is an ethical standard that ensures that participants only enrol in research 
that is consistent with their values and preferences (Emanuel et al., 2000). It requires that those 
who participate in research activities be fully informed about the research including its aims, 
procedures, risks, and benefits (UNAIDS, 2000; UNAIDS, 2012). Potential participants should 
have the freedom to agree or decline to take part (UNAIDS, 2000; UNAIDS, 2012). It is essential 
that prospective participants understand the research to which they are being invited to take 
part (Lindegger & Richter, 2000). The Declaration of Helsinki (World Medical Association, 2013) 
states that participants must demonstrate an understanding of research procedures, risks and 
benefits. Informed consent, as a major requirement for research with human subjects, is an 
expression of respect for autonomy, one of the major three ethical principles set out earlier 
(Beauchamp, & Childress, 2012). Informed consent allows participants to make an informed 
decision, hence exercising their autonomy. Sound informed consent helps safeguard the 
wellbeing of research participants by disclosing risk of harm and ensuring these are understood 
(Kruger et al., 2014).  
 
The need for ethical standards in research came to light following a series of studies which were 
conducted during World War II (Nuremburg Code, 1949). This led to the establishment of the 
first international code of ethics in 1947, the Nuremburg Code, followed by the Declaration of 
Helsinki (most recently updated in 2013) that emphasized the importance of voluntary and 
informed consent in research with human volunteers. The main focus of informed consent has 
been to protect the autonomous choice and rights of research participants (Beauchamp & 
Childress, 2012) and requires efforts to achieve adequate understanding, and to avoid forms of 
manipulation (Beauchamp & Childress, 2012). In addition to international guidelines and 
standards, many countries have developed specific guidelines on research ethics tailored 





2.6 SOUTH AFRICAN ETHICAL GUIDELINES ON INFORMED CONSENT 
 
South Africa has its own guidelines on informed consent stipulated in various documents. More 
specifically, the South African Department of Health ethics guidelines (second edition) 
published in 2015 (DOH, 2015) and the South African good clinical practice guidelines (second 
edition) published in 2006 (DOH, 2006), as well as the Medical Research Council South Africa 
(MRC) ethics policy: general principles (Book 1) published in 2001 (MRC, 2011), and finally the 
South African MRC guidelines for HIV preventive vaccine research ethics (Book 5) published in 
2003 (MRC, 2003).  
 
These guidelines underscore the need for respect for persons, and assert that participation in 
research must be affirmed by informed choices before the study begins and remain informed 
over the course of the study. Recommendations from these guidelines include: that potential 
participants should have time to consult others prior to deciding, and that RECs should assess 
‘the process’ including training of consent staff and proposed measures to assess 
understanding (DOH, 2015, p. 26). Also there should be careful design of the IC document and 
the use of culturally-acceptable language of choice and consent procedures should be tailored 
to site characteristics (DOH, 2006). Also that participants should understand the risks and 
benefits of the study before decision-making and researchers should ensure information 
presented to participants is in line with their capabilities and will facilitate comprehension of 
study information and that the investigator and team should have skills on how to conduct the 
IC process (MRC, 2001).  
 
Lastly MRC book 5 which governs all HIV vaccine trials conducted in South Africa, and was 
adapted from UNAIDS (2000), highlights the need for ‘appropriately conveyed and understood 
information as well as its consequences’ (MRC, 2003, p. 22), ‘an optimal emotional context for 
the exploration of information’ (MRC, 2003, p. 22), and sensitivity to the interpersonal 
interaction between consent staff and participants. Consent staff should ‘facilitate’ 
participants’ understanding of ‘technical concepts and their consequences, and the personal, 
psychosocial implications of trial participation’ (MRC, 2003, p. 22). It calls on study staff to 
develop skills and knowledge on how to handle some of the factors which may hinder 
understanding of study information for example social desirability where participants pretend 




2.7 COMPONENTS OF INFORMED CONSENT 
 
It has been argued that informed consent incorporates several important components: i) 
disclosure of the relevant information about the study ii) understanding of this information to 
facilitate informed decision-making iii) freedom from undue influence as well as coercion 
(threat), meaning also that participants can withdraw their permission at any time (iv) explicit 
and formal permission typically in writing (Lindegger & Richter, 2000). Poor disclosure of all 
relevant study information raises concerns about interference with the ability of the participant 
to give an authentic consent. Understanding of the relevant study information with the 
absence of coercive influences enhances free participation (Beauchamp & Childress, 2012). 
Evidence that the participant agreed should be contained in documentation kept by the 
investigator or in a signed informed consent form (The National Commission, 1979). 
 
2.8 COMPLEXITIES WITH INFORMED CONSENT  
 
Several challenges in securing informed consent for research participation have been noted 
(Kruger et al. 2014). Prospective participants often demonstrate a lack of understanding of 
concepts conveyed to them during the informed consent process. This may be because 
complex scientific terminology may not necessarily translate linguistically or conceptually into 
participants’ preferred language (Lindegger, Quayle, & Ndlovu, 2007; Stuurman, 2004; 
Watermeyer & Penn, 2008) or linguistic background (Penn & Evans, 2009). The concepts 
themselves may be difficult to understand (Ndebele et al., 2012) such as “Vaccine Induced 
Sero-Positivity” or VISP. There may be low education or low research literacy among potential 
participants (Marshall, 2007; Ndebele et al., 2012). The representation of research-related 
concepts held by potential participants may conflict with those offered by researchers 
(Newman et al., 2009; Rautenbach et al., 2015). Indigenous knowledge systems for disease and 
illness among cultural groups may differ from the explanations offered in the bio-medical 
model (Marshall, 2001, as cited in Woodsong & Karim 2005) and individual and community 
beliefs systems may serve important functions in cultural groups (Woodsong & Karim, 2005). 
Consent documents may be complex, lengthy documents at a high reading level with difficult 
terms that makes comprehension very challenging for the participants (Barata, Gucciardi, 
Ahmad & Stewart, 2006; Falagas et al., 2009, as cited in Afolabi et al, 2014; Jefford & Moore 




For a prospective participant to be able to provide consent in an informed way a good 
understanding of the key concepts is required but also of the personal implications of 
participation (Lindegger & Richter, 2000; Ndebele et al., 2012). Though the legal requirement 
of full disclosure of information may well be achieved by researchers, the ethical condition of 
ensuring that participants understand and make an informed decision may be more 
challenging (ibid). Lindegger and Richter (2000) have argued that what needs more 
recognition is how participants evaluate information for its personal implications. It is very 
challenging to measure the nature and the level of understanding that someone has of concept 
or its implications (Lindegger & Richter, 2000; Richter, Lindegger, Karim & Gasa, 1999; 
Watermeyer & Penn, 2008). Too much and too little information can undermine understanding 
– and not to exceed an individual’s “absorptive capacity” is a recognized challenge (Lindegger 
& Richter, 2000, p. 315). Another complexity is the paternalistic attitude of some researchers 
which leads to one-way sharing of information, resulting in passive consenting, where 
researchers do not come to understand the values or concerns of study participants (Lindegger 
& Richter, 2000). It has been argued that providing participants with information must not 
comprise a ritualistic recital of the written document, but should be tailored to their level of 
understanding (Marshall, 2006).  
 
2.9 THE NEED FOR COMMUNITY ENGAGEMENT TO STRENGTHEN CONSENT 
 
There is a greater appreciation that researchers should actively engage with communities to, 
amongst others, strengthen the consent process (UNAIDS/AVAC 2011). MacQueen et al. 
(2015, p. 1) defines the term community and engagement as “a group of people with some kind 
of shared social identity” and an “interactive relationship between a community and a research 
entity” respectively. It has been stipulated that a key aspect of informed consent entails the 
relationship between researcher and participant (Lindegger & Richter, 2000), and the consent 
process may be enhanced by developing a partnership between researchers and the 
community. Marsh, Kamuya, Mlamba, Williams & Molynuex (2010) highlight that community 
engagement has delivered greater opportunities for researchers to address community 
concerns and comprehension of research in general. They assert that relationships with 
community members may improve levels of trust between researchers and community 
members.  
 
A number of international and local guidelines have been developed specifically for HIV 
prevention trials which have recommended that researchers in HIV prevention trials engage 
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with participating communities to try to strengthen the consent process. WHO (2011) 
recognises the need to be sensitive to and to respect the communities’ cultural and traditional 
practices, and to identify local cultural practices which may affect the informing process. 
UNAIDS/AVAC (2011) recommends the following: identification of working structures within 
communities, understanding literacy levels of communities, and identification of languages for 
obtaining informed consent. Further recommendations from these guidelines include how 
meetings with communities should be conducted, how community representatives should be 
identified and recruited, how local language that is well understood should be used, and how 
efforts should be made to understand communities concerns, needs, and experiences and how 
research literacy should be built (UNAIDS/AVAC, 2007; UNAIDS/ AVAC, 2011). From this 
standpoint, is it evident that community engagement is viewed as facilitating the informed 
consent process (UNAIDS/AVAC; 2011).  
 
2.10 COMMUNICATING INFORMATION 
 
It has been argued that consent is best conceptualized as “a process, ideally a dialogue, that 
takes place over time and depends on interactions between human beings” (Flory & Emanuel, 
2004). It has been argued that principles of adult learning, as well as communication may 
helpfully inform the issue of how to communicate complex information in the consent process 
(Flory & Emanuel, 2004; Meade, 1999). Both may inform the interpersonal processes or 
strategies employed when interacting with other people (Hargie, 2011) for informed consent. 
In the section below, some key principles from both fields relevant to consent are briefly 
reviewed. 
 
2.10.1 ADULT LEARNING  
Research with learners has shown that adults learn in a specific way and have several 
characteristics (Ota, DiCarlo, Burts, Lairds & Gioe, 2006). Ota et al. (2006) have stipulated that 
adults have special needs which require careful consideration when one wants to impart 
knowledge to them. Adults acquire knowledge better if they associate new knowledge and 
information with formerly learned information, experiences and knowledge. A key principle of 
adult learning is that adult learners are not blank slates and bring a rich and extensive bank of 
experiences from which to draw when learning new material (Robin & Fogarty, 2007). That is, 
prior knowledge is considered critical when constructing new knowledge (Popkewitz et al., 
2001, as cited in Martin, 2006) and where comprehension of key concepts is held to depend on 
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existing frames of reference (Martin, 2006). This suggests that researchers should make some 
effort to assess prior knowledge of potential participants bearing in mind that some people may 
overestimate what they know particularly in complex fields (cf. Dunning, 2014).  
 
Also, learners are viewed as active participants in the learning process, and therefore it is 
recommended that learning encounters provide opportunities for adult learners to interact 
with each other and the educator (Dunning, 2014). This suggests that encounters where 
complex trial information is presented should be structured in a way that encourages 
participation. Furthermore, it is recognized that adult learners are most interested in 
information relevant to their needs; and that communication that emphasizes ‘the facts’ alone 
is inadequate because learner may not be sure what they are supposed to do with the facts 
(Meade, 1999, p. 125). This suggests that encounters where trial information is being disclosed 
should explore the needs of those ‘learning’, and try to balance the required elements of 
informed consent with the informational needs of subjects (Meade, 1999). This also suggests 
that implications of trial ‘facts’ should be explored with potential participants so they are able 
to appreciate the facts in terms of their daily personal lives (cf. Lindegger & Richter, 2000; 
Ndebele , 2010; Ndebele, Wassenaar, Masiye & Munalala-Nkandu, 2014). The above principles 
suggest that research staff should plan activities geared towards the acquisition of new 
concepts, skills, and attitudes (Popkewitz et al., 2001, as cited in Martin, 2006). 
 
2.10.2 HEALTH COMMUNICATION  
Health communication is useful for facilitating health decision-making, and ensuring 
adherence to health interventions by patients (Ahmed, Hossain & Kabir, 2014) . Health 
communication posits that there should be active participation by the patient in the exchange 
of information, rather than unilateral disclosure and passive reception of information by the 
patient. This suggests that encounters where key trial information is disclosed should ensure 
that potential participants are actively involved in the interaction, and that relevant 
information should be conveyed in focussed interactions that help participants to understand 
information and to choose an action corresponding with their health beliefs and desires 
(Meade, 1999).  
 
It has been argued that key communication practices include both inquiring and informing - to 
assist patients to make decisions about treatment options that are shared between doctor and 
patient (White, Keller & Horrigan, 2003). Inquiring involves asking patients about their existing 
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beliefs, preferences, understanding and values while informing involves providing the patient 
with information about the clinical evidence, options, risks and benefits (White et al., 2003). 
Inquiring is viewed as helpful for assessing the patient’s knowledge, expectations, fears, and 
their beliefs that may have been derived from lay networks or other information sources 
(Charles, Gafni & Whelan, 1999; White et al, 2003). In this framework, a patients’ 
comprehension is seen to depend mostly on the quality of communication from those 
providing consent (Albrecht, Franks & Ruckdeshel, 2005). This suggests that qualities of 
consent communicators are critically important (Cohn & Larson, 2007).  
 
Many commentators have recommended good practices for communicating complex 
information for research including the following: establishing rapport with the participants 
(Penn & Evans, 2009), knowing more about the study participants (Penn & Evans, 2009), 
facilitating dialogue with the participant (Wade, Donovan, Lane, Neal & Hamdy, 2009), using 
language that is easy to understand and preferred by the participant (Watermeyer &Penn, 
2008), encouraging participants to ask questions, creating an interaction during the process 
(White et al., 2003), verifying understanding and assessment through culturally-relevant 
methods, or asking the participants to explain in their own words (Ndebele et al., 2012; 
Ndebele et al., 2014), and ensuring opportunities to discuss the information with others (Wade 
et al., 2009). From this standpoint, informed consent should be viewed as a requiring an 
effective communication process that fulfils requirements for consent and allows potential 
participants to make informed decisions about research participation (Meade, 1999).  
 
2.11 THE MEERWEIN MODEL OF THE INFORMING PROCESS 
 
Some commentators have identified various dimensions to be addressed during the informing 
process (Ndebele, 2010; Tomamichel et al., 1995). The Meerwein model (Meerwien, 1985, as 
cited in Tomamichel et al., 1995) asserts that there are three main dimensions of the informing 
process namely an informational, emotional and relational dimension (Tomamichel et al., 
1995). In the model as adapted by Tomamichel et al. (1995) the informational aspect is 
concerned with the information itself and how it is explained, the emotional aspect is 
concerned with how emotions are addressed, and the interactive dimension is concerned with 
the capacity and willingness of the researcher to perceive and respond to needs and concerns 
of participants (Tomamichel et al., 1995). It is held to recognize important aspects of the 
investigator-participant relationship that impact on informed consent, namely, to 
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communicate complex information, to address emotions and to respond to concerns of 
participants (Tomamichel et al., 1995). The model has been mentioned as a valuable tool in 
teaching communication skills (Tomamichel et al., 1995). This model recognizes that 
“informing” is a process that comprises crucial features with regard to the manner in which 
information is provided and the relationship between the potential participants and the 
researcher (Ndebele et al., 2014).  
 
 
Figure 2: Meerwein model of the informing process (Ndebele, 2010) 
 
Furthermore, a commentator has used the Meerwein model to develop a framework 
comprising three stages (Ndebele, 2010). During the first stage, the investigator invites the 
potential participant to inform them about the study. The participant - upon acceptance of the 
invitation - is then provided with detailed information. The second stage involves the two 
parties having a discussion about fears, concerns, and questions. This stage involves provision 
of more focused and detailed information to ensure comprehension of study procedures and 
to build trust. The third stage is realised after utilisation of information where the potential 
participants decides whether to enrol into a study or not, after deliberating on the information 
which has been provided (Ndebele, 2010). The stages and key features are summarised in a 







How information is 




Willingness of researcher to 
perceive and address emotions
INTERACTIONAL 
DIMENSION:






Dimension Stage Key elements(Participant)  Key elements(Researcher) 
Informational Informing • Processing information 
• Having adequate time to 
process information and 
consult  
• Providing sufficient 




• Having opportunity to 
ask questions 
• Expressing fears and 
myths/ misconceptions. 
 




• Addressing fears, 
myths and 
misconceptions 











Table 1: Tabular representation of Meerwein stages and features as described in Ndebele 
(2010) 
 
2.12 RELEVANT EMPIRICAL RESEARCH  
 
CIOMS (2002, p. 33) guideline 4 states; 
…obtaining IC is a process that is begun when initial contact is made with prospective 
participants and continues throughout the course of the study - by informing the 
prospective subjects, by repeating and explanation, by answering their questions as they 
arise and by ensuring that each individual understands each procedure, investigators elicit 
their IC and in so doing respecting their dignity and autonomy. Each individual must be 
given as much time as is needed to reach a decision, including time for consultation with 
family members or others. Adequate time and resources should be set aside for informed-
consent procedures.  
 
However several commentators have argued that there is still much to know about the quality 
of the verbal interaction during the consent process (Brown, Butow, Butt, Moore & Tattersall, 
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2004) and about the strategies being implemented to improve consent, so that comprehension 
of trial information is enhanced. Over the years, there has been some research exploring 
consent communication, for research generally and for HIV vaccine trials specifically, and a 
selection of key articles is briefly reviewed here.  
 
2.12.1 STUDIES ON NON-HIV PREVENTION CONSENT RESEARCH 
Flory and Emanuel (2004) conducted a systematic review of 42 trials that compared the 
understanding of research participants who had undergone a standard informed consent 
process to that of participants who had received an intervention to improve their 
understanding. Their findings concluded that “extended discussion” and holding one-on-one 
discussions with participants appears more effective in improving understanding than 
enhanced consent forms and multi-media interventions” (Flory and Emanuel, 2004, p. 1599). 
The authors hypothesized that “direct human contact” has more potential for active 
engagement and responsiveness to the individual needs (Flory and Emanuel, 2004, g. 1599) 
Also, Nishimura, Carey,Erwin, Tilburt, Murad, & McCormick (2013) conducted a review of 39 
consent trials and concluded that enhanced consent forms and “extended discussion” are most 
effective in improving participants’ understanding (Nishimura et al, 2013) .  
 
Ahmed et al. (2014) conducted a survey with 25 households selected at random from 30 Mauza 
villages in Bangladesh, India. The survey was conducted to explore the role of various 
communication media in enhancing understanding to facilitate informed decision-making for 
managing malaria-like illnesses. The findings indicated that interpersonal communication was 
viewed as more effective in improving knowledge than conventional print and audio-visual 
media. This author agreed with Flory and Emanuel (2004) that interpersonal processes are 
effective in improving understanding for research participation (Ahmed et al., 2014).  
 
Saidu (2013) conducted a study with 200 mothers who provided informed consent for their 
children to take part  in a Phase II randomized, controlled and observer-blind trial to evaluate 
the impact of a combined protein-polysaccharide vaccine on nasopharyngeal carriage of 
Streptococcus pneumoniae in Gambia. The findings showed that provision of trial-related 
information on separate (repeated) occasions enhanced the understanding of study 
information by study participants. Wade et al. (2009) conducted a study investigating what 
occurs during informed consent procedures in an ongoing multi- center randomised clinical 
trial in the UK. The study recruited 23 men aged 50–69 years old. The study showed that 
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eliciting views from participants enables participants to raise their concerns, as well as to state 
their beliefs which require clarification from research staff. They argued that eliciting and 
exploring beliefs is crucial for the consent discussion (Wade et al., 2009).  
 
In an analysis of communication through translators (experts in local language) in health-care 
settings, Kaufert and Putsch (1997) explored concerns that arise from differences in culture and 
language. They conducted interviews (and gathered observational data) regarding the 
experience of 10 Canadian medical interpreters from a palliative care group. Their findings 
concluded that, in multicultural contexts, in order to develop a culturally-sensitive approach 
which may enhance health-care decisions, cultural competency is crucial. Carrese and Rhodes 
(1995) explored the use of language and its implications for disclosure of medical information 
amongst the Navaho nation in the USA and illustrated that language can exert powerful 
restrictions on medical communications.  
 
Molyneux, Peshu & Marsh (2004) argued that a major tool in improving understanding includes 
pro- active (community based) information-giving, including holding workshops and open 
days at research centres and in communities where potential participants are encouraged to 
ask questions and start discussions. They asserted that having lengthy discussions in local 
language makes scientific terms more understandable to local individuals (ibid). Penn and 
Evans (2009) conducted a study in a large multi-site HIV treatment trial in South Africa. The 
study recruited 13 counsellors who had been trained to recruit patients with HIV or AIDS who 
were receiving ART. The first languages of the counsellors included Xhosa, Zulu and Sesotho. 
The study compared a standard protocol with a modified protocol matching the cultural and 
linguistic variables. In the latter protocol, the counsellors were encouraged to learn 
participant’s language preference, deliver the message in several languages (code-switch) and 
explain simply. The authors recommended attention to language as a critical part of 
communication during consent, and attention to staff training as a key strategy to help 
participants comprehend study information. They recommended that consent staff should 
have the ability to display understanding of the content, should be able to explain clearly to 





2.12.2 STUDIES ON HIV PREVENTION CONSENT RESEARCH 
Ndebele et al. (2012) conducted a study in Malawi to assess HIV prevention trial participants’ 
understanding of randomisation, double-blinding and placebo use, and found lower scores on 
certain complex concepts such as double-blind, and on the personal implications of 
participation. In a later paper, Ndebele et al. (2014) investigated the impact of an intervention 
on the understanding of low-scorers from the first study. The study intervention included: 
using laymen’s language, using narratives of key concepts and their personal implications 
based on every-day examples from the Agricultural field (because Malawi has an agriculture-
based economy), power-point presentations, and discussion of the concepts. The findings 
showed that low scorers assigned to the intervention had improved understanding compared 
to the control. Furthermore, information presented in the form of story “vignettes” was 
considered to be interesting and easy to follow. This represented the importance of 
encouraging participant’s to understand research concepts by invoking real-life, every-day, 
meaningful, locally relevant examples or scenarios (Ndebele et al., 2014).  
 
Fitzgerald, Marotte, Verdier, Johnson & Pape, (2002) in a study on HIV-1 transmission in Haiti 
enrolled 15 individuals who were given information during a single meeting with a physician 
and 30 volunteers who were given information by a counsellor during three meetings (with 
discussion), and the results indicated a 20% versus 80% pass score on oral examination 
respectively. They argued that holding multiple sessions of informed consent in 
communicating complex information increased the comprehension of members of a Vaccine 
Preparedness Group (Fitzgerald et al., 2002). Harrison, Vlahov, Jones, Charron, and Clements 
(1995) enrolled volunteers from the Injection Drug Use (IDU) population into a study exploring 
their levels of understanding – before their enrolment into a multicentre Phase II trial of two 
HIV recombinant GP 120 sub-unit vaccines. The study administered a forced choice checklist 
to assess understanding of study procedures prior to written informed consent. They found 
relatively high levels of knowledge, and concluded that this population could be assisted to 
comprehend the study, and identified foci for further education about the study protocol.  
 
McGrath et al. (2001) conducted a study to find the best way to educate potential participants 
about phase III HIV vaccine trials and to evaluate their understanding of study information in 
Uganda. They enrolled 1,182 Ugandan military men who received education about vaccine 
trials and were interviewed 24 months later in follow up. The study intervention was vaccine 
trial education which provided detailed information about phase III vaccine trials, and an 
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interactive group format. The study team translated the information into local languages and 
employed the use of analogies for concepts like ‘randomisation’ and ‘placebo’. It was reported 
that participant’s levels of understanding in the enhanced educational programme was higher 
than in the control group. The findings underscored the need for repeated and ongoing trial 
education to impart knowledge about HIV vaccine trials concepts.  
 
In summary, informed consent is critical for research because it acknowledges that individuals’ 
need to be respected as worthy and capable of making individual choices given the right type 
of knowledge (Ng’ongo’la, 2016). Engagement of the participating community might help to 
make consent processes stronger (UNAIDS/AVAC, 2011). Efforts to communicate complex 
information in a way that optimizes understanding become very important. Current ethical 
guidelines for HIV vaccine trials (MRC, 2003) assert that interpersonal skills and processes to 
facilitate sound understanding are critical. However, there has been little research that 
explores the strategies being used by key HIV vaccine stakeholders to help communicate trial 
information (Penn & Evans, 2009; Slack et al., 2016). This study aims to fill that gap by 
exploring strategies reportedly being used by site-staff communicating trial information to 








STUDY AIMS AND METHODS 
 
3.1  INTRODUCTION 
 
This chapter will describe the study aims, the approach to the study, and the methods used to 
collect and analyse the data. It will motivate the methods employed, and describe measures 
implemented to ensure rigour of the study. Ethical considerations addressed during the 
conduct of the study will also be described. 
 
3.2 STUDY AIMS 
 
This study aimed to explore practices reportedly used to communicate complex concepts in 
HVTs. More specifically it aimed:  
• To explore strategies reportedly used by key site stakeholders in South African HVTs 
to communicate trial information 
• To explore the correspondence of reported strategies with recommended practices 
from the conceptual and empirical literature  
• To explore the implications for strengthening the informed consent process in 
resource-constrained settings.  
 
3.3 STUDY APPROACH 
 
This study adopted a qualitative approach. This approach is useful for an in-depth or detailed 
exploration of a phenomenon in context (Mack, Woodsong, MacQueen, Guest, & Namey, 
2005; Ulin, Robinson & Tolley, 2005). It strives to allow the researcher to understand a given 
research problem from the perspectives of the population participating in the research (Mack 
et al., 2005. Ulin et al. (2005) state that qualitative methods are naturalistic, insofar as they 
apply to real-world circumstances as they unfold naturally. Terre Blanche, Durrheim and 
Painter (2006) assert that this approach is useful for the study of unfolding processes in real 
situations. The approach is generally inductive, where findings materialize from themes 
inherent in the data, without the limitations imposed by organized methodologies (Strauss & 
Corbin, 1998) and is concerned with people’s experience-near perspective - that allows the 
researcher not to start exclusively with prior concepts but to allow important concepts to 
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emerge from engagement with the data (Ulin et al., 2005). Qualitative research is oriented 
toward discovery and process (Mack et al., 2005). It is argued to be an ideal approach for the 
collection of information about the view-points and behaviours of those participating in the 
study (Mack et al., 2005). For the reasons above, a qualitative approach was considered 
appropriate for an exploration of the strategies used to communicate complex information in 
HIV vaccine trials to potential trial participants, and for addressing the aims in this thesis.  
 
This qualitative study was broadly set in an interpretive perspective – focusing on practices, 
subjective meanings that stakeholders may attach to their practices, and the context (Ulin et 
al., 2005). This framework - which emphasizes people’s perspectives linked to their practices – 
seemed to be a useful one in which to locate the study because the study was interested in the 
perspectives of site stakeholders linked to their practice reports of communicating complex 
information to potential participants (Ulin et al., 2005).  
 
3.4 STUDY METHODS 
 
3.4.1 BACKGROUND AND REFLEXIVITY  
The researcher has had several work-related experiences that led to her interest in informed 
consent. As a Quality Control/ Quality Assurance Officer at the University of North Carolina 
Research Project in Lilongwe, Malawi, she has reviewed informed consent forms for 
completeness. While doing this work, she experienced some concerns about the length of 
informed consent forms and scientific terminology used. The length of the consent form left 
her thinking about how potential participants affected by HIV might have to spend several 
hours working through the information, and wondering how their expectations, fears and 
concerns would be addressed. She also questioned how medical terms might be adequately 
translated in the local language (Chichewa) which is very limited in terms of scientific 
words/phrases. As a Co-Investigator on a study protocol exploring management of diabetes in 
patients living with HIV and AIDS, she was responsible for informed consent processes – more 
specifically her main role was to enrol potential participants into the study which included 
ensuring that they were given adequate information about the study and that they 
comprehended the information. Here she had personal experience of interacting with 
potential participants with little background in research, little formal education, and diverse 
cultural backgrounds. Here, she noticed efforts to try ensure understanding of the concept of 
‘efficacy’ by referring to local cuts called “kuwalitsa mphini” (i.e. traditional marks put on parts 
of the body using a sharp object, where traditional concoctions are added to prevent different 
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diseases). The experience also allowed her to see the importance of regarding informed 
consent as a process where a researcher and a potential participant discuss the study, where 
participants can be active inquirers; but also allowed her first-hand experience of how 
challenging that can be.  
 
Also, through her work at Malawi Liverpool Wellcome Trust, she became interested in the issue 
of communication because she was instrumental in providing training to study-staff on 
informed consent so the requirements stipulated in ethical guidelines (such as Declaration of 
Helsinki, 2013) could be met. Here she heard many challenges research staff encountered when 
conducting informed consent, e.g., how to ensure participants are fully engaged during the 
process, how to handle participants with myths and misconceptions; and how to address 
potential participants cultural beliefs about traditional medicine. As a result of these 
experiences, she became motivated to explore empirically the issue of how to strengthen the 
communication of complex information for research participation. As part of her Master’s 
degree in Social Science (Health Research Ethics) funded by the South African Research Ethics 
Training Initiative (SARETI) the researcher became aware of a research project exploring 
informed consent in HIV vaccine trials being conducted by the HIV AIDS Vaccines Ethics Group 
(HAVEG), and she approached HAVEG staff to explore becoming involved in the study for her 
dissertation requirement.  
 
3.4.2  DESIGN 
This study comprised an analysis of existing data collected previously by members of HAVEG 
at the University of KwaZulu-Natal (UKZN). The broader HAVEG study, of which this analysis 
was a part, was reviewed and approved by several Research Ethics Committees, namely the 
Human and Social Sciences Research Ethics Committee at the University of KwaZulu-Natal 
(UKZN HSS REC 1332/012); University of Cape Town Human Research Ethics Committee (UCT 
HREC 213/2013; and the University of Toronto Institutional Review Board (UoT IRB 28859). The 
analysis of existing data for this thesis was approved under existing approvals. (see Appendix 
1). This study was also approved by Higher Degrees Committee at the College of Applied 
Human Sciences UKZN, namely HSS/1236/015M. .   
 
The broader HAVEG study aimed to explore representations of key trial-related concepts, as 
well as to explore interpersonal processes between key site-stakeholders and potential 
participants geared at enhancing comprehension of complex trial information or other 
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important outcomes. The broader HAVEG study therefore aimed to explore how complex 
information is communicated to participating-community members and potential participants 
during consent-related discussions at South African HIV vaccine trial sites - to inform sound 
decision-making for HVTs. The HAVEG team had already undertaken a separate analysis of the 
data to explore how key concepts were represented by various groups and identified various 
‘competing versions’ or explanations of key consent concepts (Rautenbach et al, 2015). HAVEG 
was embarking on an additional analysis of how trial information was communicated to 
potential participants, and the researcher was invited to contribute to this analysis of collected 
data, as part of her Masters dissertation. 
 
3.4.3  SAMPLE 
The HAVEG study had already recruited participants from key stakeholders at an HIV vaccine 
trial site with varying types of experience related to the issue under exploration, including 
Community Advisory Board members who interact with participating-community members; 
Educators who interact with interested community members at the site, and Consent 
Counsellors who interact with persons interested in enrolment in actual HIV vaccine trials. This 
reflected a form of purposive, non- probability sampling to include information-rich cases 
(Starks & Trinidad, 2007; Terre Blanche et al., 2006) and to identify specific groups of people 
who had knowledge relevant to the phenomenon being studied, and to enable exploration of 
strategies being used every day when communicating complex concepts in such trials. A range 
of informants was included to provide rich and possibly diverse sources of knowledge on the 
subject (May & Pope, 1995). HAVEG had already recruited an additional key informant, a site-
staff member at the site knowledgeable about site processes.  
 
3.4 4  DATA COLLECTION  
HAVEG staff members had conducted Focus Group Discussions (n =4) with representatives 
from three site-related constituencies, namely CAB members, Educators and Consent 
Counsellors. Two FGDs had been conducted with 10 CAB members each (i.e. 20 CAB-enrollees) 
late in 2013. One FGD with 8 Educators had taken place also late in 2013 (i.e. 8 educator-
enrollees). One FGD with Consent Counsellors with 7 members had been conducted in early 
2014. The FGDs were conducted in English, yet participants did speak in the language 
prevailing in the participating community as well. In the FGDs, several domains were explored, 
that is, HAVEG staff asked representatives to describe their role, to discuss trial information, 
how information is explained (including the use of analogies) and challenges they experienced. 
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Also, facilitators and FGD-participants engaged in role-playing – where explanation of 
concepts to ‘pretend’ participating-community members was role-played, in order to stimulate 
discussion about the information, how it is communicated, and challenges (cf. Rautenbach et 
al., 2015; Slack et al., 2016).  
 
Sessions were audiotaped with permission and transcribed verbatim in English. (See also 
‘ethical considerations’ section that follows later). The foremost advantage of FGDs is that they 
produce  more  information over a short period of time, and are effective in eliciting a 
comprehensive, diverse range of views on a specific topic (Mack et al., 2005). The semi-
structured approach allows issues to be explored flexibly (Denscombe, 2003), and allows FGD-
participants to communicate their experiences and describe their opinions in their own words, 
with no restrictions, and according to their knowledge and experiences (Terre Blanche & 
Durrheim, 1999).  
 
3.4.5  DATA ANALYSIS 
The data set for this analysis comprised existing transcripts from 4 FGDs which constituted the 
“primary” data and 1 semi-structured interview as “secondary” data. After signing a 
Confidentiality Agreement, the transcripts were made available to the researcher. These 
transcripts were analysed using Thematic Analysis (Braun & Clarke, 2006). This was used 
because Thematic Analysis allows the identification, analysis and reporting of patterns or 
‘patterned responses’ (themes) within a data set (Braun & Clarke, 2006, p.85). Another 
advantage of Thematic Analysis is that it is theoretically ‘flexible’ and is used across different 
qualitative frameworks (Braun & Clarke, 2006, p.28). For this study, it was suitable to answer 
questions related to people’s experiences about communication strategies used in 
communicating complex information, and was also able to capture experiences in the form of 
viewpoints and perceptions (Braun & Clarke, 2006). The researcher’s approach to analysis was 
informed by a step-by-step guide by Braun & Clarke (2006) with some variation. The following 
steps were taken:  
 
Step 1: Reading and becoming familiar with the data: The researcher repeatedly read the data 
in an “active way” (Braun & Clarke, 2006, p. 16), searching for patterns. At this stage the 
researcher started taking notes, marking ideas for coding, and highlighting interesting quotes. 
This allowed the researcher to familiarize herself with the aspects of the data. The researcher 
read each transcript with the primary issue in mind – namely what are the strategies being used 
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to communicate complicated trial information? This helped to focus reading of the transcripts 
based on the main study question.  
 
Step 2: Coding: Text was coded by giving portions of the text particular labels (Boyatzis, 1998, 
as cited in Braun & Clarke, 2006). Coding was guided by the central aims of the study. Text was 
labelled according to strategies or processes being used to communicate complicated 
information. The features of the data which appeared interesting to the researcher from the 
transcripts were extracted and placed into a coding table. Some codes were developed from 
reading the literature such as ‘using analogies’ and these constituted deductive or top-down 
codes (Quinn-Patton, 2002). Others were developed from the reading of the transcripts such 
as ‘referring to safe licensed vaccines’ and these constituted inductive or bottom up codes. Text 
was labelled in a semantic way, staying fairly close to the words used by study participants 
(Sandelowski, 2000).  
 
Step 3: Sorting codes into clusters: At this time the researcher began to form ideas about how 
codes might relate to each other (Green et al., 2007). Codes were examined to see if they could 
be linked together to create coherent clusters (Green et al., 2007). For example the codes: 
‘referring to safe licensed vaccines’ and ‘using trustworthy sources’ were clustered together 
because these appeared to be concerned with addressing suspicion or fear.  
 
Step 4: Sorting code-clusters (sub-themes) into master themes: The data was examined to 
establish how sub-themes could be organized into higher-order master themes. Here the 
model advanced by Meerwein (1985, as cited in Tomamichel et al., 1995) was considered 
useful. As set out in the previous chapter, this model comprises of three dimensions namely: 
informational, emotional and interactive/ relational dimensions. The informational dimension 
covers how well a communicator explains important content or information; the emotional 
dimension addresses how well the communicator addresses feelings, and the interactive 
dimension addresses various relational elements such as how well a communicator responds 
to participants needs and concerns. This framework was not adopted in totality but rather it 
informed the development of the master themes. The list of codes, code-clusters and themes 
(and supporting quotes) was regularly discussed and reviewed with the supervisor (see section 
3.5). The final code/theme list is set out in Chapter 4 (Results). Word processing software was 




Step 5: Writing themes into narratives: A detailed description was written for each theme (Braun 
& Clarke, 2006). The narrative identified the “story” each theme was telling (Braun & Clarke, 
2006., p. 90). These narratives identified the strategies being used to communicate trial 
information by key site stakeholders in important encounters at trial sites. Each theme was 
supported by the best data extracts. The narrative and selected quotes aimed to demonstrate 
the relevance of each theme and how it fits into the overall aim of this study.  
 
3.5 STUDY QUALITY 
 
The researcher set out her experiences and personal involvement in the subject matter 
(Malterud, 1993) in order to include a brief reflexive account that may show the influence of the 
researcher on the aims and the material considered relevant. The researcher reflected on her 
past experience in informed consent encounters as an educator and trainer (including 
challenges related to informed consent encounters) which informed her current research 
interests in strategies to enhance comprehension in HIV vaccine trials. She engaged with an 
interrelated body of empirical work which informed her research analysis. Also, the sampling 
method allowed the inclusion of multiple different perspectives from various stakeholders 
about the issue under investigation (Patton, 1999) to allow suitable diversity and scope.  
 
Furthermore, a selection of transcripts were co-coded by the supervisor and discrepancies 
resolved by “reconciliation discussions” (Boyatzis, 1998, p. 152). To ensure development of 
comprehensive codes, and their consistent application, there was comparison of coding and 
discussion between student and supervisor which helped ensure that codes systematically 
accounted for all of the emerging data (Green et al., 2007). This process provided an important 
check on selective perception (Patton, 1999). In addition, the student and supervisor ensured 
that themes cohered around a central concept and were sufficiently distinct from each other 
(Braun & Clarke, 2006). Finally, in order to verify that all codes still applied or whether the older 
transcripts needed re-coding, previously coded transcripts were revisited (Green et al., 2007). 
Saturation was considered reached when new transcripts did not lead to further elaboration of 
codes and themes (Green et al., 2007). The researcher systematically made inquiries of the 
transcripts to ensure that the emerging analysis responded adequately to the research aims 




3.6 ETHICAL CONSIDERATIONS OF THE STUDY 
 
3.6.1  INDEPENDENT REVIEW 
As discussed earlier, this analysis of existing data obtained ethical approval. 
 
3.6.2  STAKEHOLDER ENGAGEMENT  
The HAVEG study ensured that stakeholder engagement at the relevant site was conducted to 
ensure buy-in and support. HAVEG members conducted presentations to describe the study, 
to hear concerns and to tailor the data collection accordingly. Permission to enter the site for 
the HAVEG study was obtained from relevant gate-keepers at the site, such as the site 
leadership and CAB leadership.  
 
3.6.3  INFORMED CONSENT 
The HAVEG study sought individual, written informed consent from each participant before 
data collection. Participants were informed about the study, and given the opportunity to 
discuss the study with the researchers. The research team ensured that all respondents signed 
the informed consent form and agreed voluntarily to participate in the study. The team also 
ensured that consent for recording of FGDs was obtained. Before the start of the FGDs, the 
research team described the aims of the study, and provided an opportunity for participants to 
ask questions and to present their concerns. Participants were assured of anonymization of the 
transcripts and secure storage of data.  
 
3.6.4  RESPECT FOR RECRUITED PARTICIPANTS 
The HAVEG study ensured that redaction of names and identifying details from study 
transcripts was implemented, to maintain anonymity of participants. In order to maximize 
protection of study records electronically, transcripts were password protected and, to ensure 
secure storage of study materials, study documents were locked in cabinets. To ensure sound 
data management, the audio-files were password protected. Data was stored in a secure 
environment including password-protected computers (for electronic files) and locked 




3.6.5  FEEDBACK TO PARTICIPATING SITE  
The HAVEG team has provided feedback to the participating site about emerging results. 
Relevant findings from this analysis will be summarized as part of appropriate feedback for 
participants and stakeholders at the participating site.  
 
3.7 STUDY LIMITATIONS 
 
This study data comprised mainly of FGDs at only one site. This means that caution has to be 
exercised when generalizing the findings beyond the site, however, it is possible that other 
sites using the similar approaches and staffing might find the results useful (Slack et al., 2016). 
The study did not make use of any observational methods, but relied on self-reported practices 
(Slack et al., 2016). This means that some techniques which are not easily apparent to such 
staff might not be reported (for example, they may have forgotten about them). This also 
means that site stakeholders may report certain strategies but they do not actually implement 
them in practice, for example, site stakeholders may have experienced some ‘social 
desirability’ pressure to report communication practices because that was the focus of the 
study – even though they do not implement them. That is, they may have wished to please the 
investigators and to make a favorable impression (Lindegger & Richter, 2000). Observations 
would have allowed a richer understanding of the setting and the conduct of the members in 
that setting (Jorgensen, 1989).  
 
The methods employed here cannot ‘validate’ the actual practices being used. Also the views 
of potential participants were not canvassed and the study did not identify different 
perspectives between stakeholder groups, which would have allowed the issue to be explored 
from a critical perspective. As set out in Slack et al. (2016) potential participants could have 
described their experiences of practices implemented to communicate with them, including 
what was useful or valuable to them – which would have increased the value of the data 
collected (Frechtling & Sharp, 1997). The FGDs were conducted by English facilitators, even 
though FGD participants spoke in both English and the local language during the FGDs. 
Because FGD participants may have experienced implicit pressure to communicate in English, 
this may have restricted their spontaneous communications, and impacted on the richness of 
data.  The use of existing data imposed certain limitations because the analyst could not ask 
questions in subsequent focus groups based on analysis of earlier focus groups; rather the 




CHAPTER FOUR  
RESULTS 
 
4.1  INTRODUCTION 
 
This chapter sets out three master themes as developed by the analysis described in the former 
chapter. In the subsequent chapter, these strategies are located in the existing theoretical and 
empirical literature.  
 
4.2  FOCUS GROUP DISCUSSION (FGD) PARTICIPANTS 
 
The 35 FGD participants comprised a mix of men and women – 40% were male and 60% were 
female. They comprised participants with varying degrees of experience in their role. Most 
were fluent in the language prevailing in the participating community. One person involved in 
site management functions took part in an interview which comprised supplementary data.  
 
4.3  THEMES 
 
Theme 1 sets out findings related to strategies implemented by CABs, Educators and Consent 
Counsellors to communicate complex information (the informational  theme); theme 2 sets out 
findings related to strategies implemented to address emotions (the emotional theme); and 
theme 3 sets out findings related to strategies implemented to develop respectful relationships 
with participating-community members and potential participants (the relational theme). The 
themes, sub-themes and codes have been summarised in the Table below:  





• Recognising challenges 
with information-provision 
 
• New information 
• Complex/complicated information 
• Too much information 
• Participants with little educational background 
• Participants with little background in research 
• Participants use language with no research terms. 





• Ensuring language preference 
• Code-switching 
• Using supplementary aids 









• Recognizing negative 
emotions 
• Fear of exploitation 
    - Site selection/ targeting black communities 
    - Guinea pigs/using people as guinea pigs 
    - Blood selling 
• Fear of harm from vaccine research 
    - Side effects 
    - Being infected with HIV 
• Feeling of hopelessness 
    - Hope 
• Feeling of mistrust/ suspicion 
    - Of site representatives 
    - Of CABS 
    - Of the site itself 
     - Of researcher/medical researchers/white 
researcher 
• Responding to negative 
emotions 
• Inquiring about/ collating suspicions 
        - Asking about/ exploring 
        - Keeping record 
• Using trustworthy sources 
        - Ex-participants (‘witnessing’) 
        - Community members/ influential community 
members 
        -CAB 
• Referring to safe, licensed vaccines 
        -Polio 
        -Other childhood vaccines  





• Recognizing cultural 
norms  
• Cultural norms/ differing across sites 
• Trying to please persons in authority 
• Believing in traditional medicine 
• Talking about body parts or sex 
• Responding to cultural 
complexities 
• Requesting permission to break cultural norms 
• Matching culture/races 
• Using culturally acceptable terms/words 
• Raising awareness about western medicine 
• Showing general respect • Greeting 
• Making comfortable 
• Offering refreshments 
• Encouraging 
• Assuring about confidentiality 
• Giving time to decide 
Table 2: Themes, sub-themes and codes 
 
4.3.1 THEME 1 - INFORMATIONAL ISSUES 
 
This theme describes how site stakeholders (CAB members, Educators and Consent 
Counsellors) faced challenges with providing information to participating community 
members and potential participants and describes how they attempted to address 




4.3.1.1 Recognising challenges with information-provision 
CAB members, Educators and Consent Counsellors all acknowledged facing challenges with 
providing information to participating communities and potential participants. It was reported 
that a lack of formal education made it difficult for potential participants to understand complex 
concepts in HIV/AIDS vaccine research, for example, the concept of VISP or ‘Vaccine Induced 
Seropositivity’ where participants test HIV ‘positive’ but they are not infected with HIV. Site 
stakeholders recognised the need to take inadequate education into consideration, as well as 
little knowledge or experience with HIV vaccine trials, or research in general. Site stakeholders 
reportedly used various strategies to ‘inform and educate’ communities about research, 
vaccine trials and HIV/AIDS trials, and the following quote illustrates this point: 
I personally discovered that it’s 95% of people, in, the areas we working to, they don’t have 
much information, about vaccine which is now what our outreach worker/ outreach workers 
it’s our role (…) that we make sure that that 95% that doesn’t have much information or, 
like, the basic information about vaccine and about what the trial .We make sure that we 
educated them. (FGD 3, Educators) 
 
CAB members and Consent Counsellors recognised the challenge of language barriers which 
existed between some members of the research team and participating communities/ 
potential participants. It was reported that many scientific words terms do not exist in the 
indigenous language prevailing in the community – which presented these stakeholders with 
a challenge - as one Consent Counsellor remarked: 
Most of the scientific terms do not exist at all, in the indigenous language, so we have to 
make a sentence in order to define that word. (FGD 4, Consent Counsellors) 
 
CAB members and Consent Counsellors also acknowledged how complex HIV vaccines trials 
terms are – that is, the concepts that have to be transmitted are in and of themselves fairly 
complicated, but critical to understand because there may be consequences for participants. 
The concept of VISP or ‘Vaccine Induced Seropositivity’ was described as especially 
challenging. An Educator illustrates this point in the following quote: 
… another thing that needs to explain to the participant is this VISP thing is very crucial, 
very crucial, and I mean, they need also be explained that how long this VISP going to stay. 
You know because, I heard that it can be, stay it can stay in you about 15 years (…) You 




Consent Counsellors admitted that they encounter challenges in communicating concepts at 
the beginning of any trial - illustrated in the following quote: 
Then we will start having a way of unpacking. Because, honestly for each and every new 
study, at first we struggle as counsellors. Cause one, you are trying, to get through this, to 
transfer that. (FGD 4, Consent Counsellors) 
 
Consent Counsellors also described that there was so much information to disclose. These 
reports appeared to be concerned with the volume of information that has to be disclosed and 
processed in the time-frame that is available. As one recounted:  
So for us we find it is very strenuous but there are these clauses that limit us that come 
from the sponsor that part of these visits these are the consents. Cause we feel it’s too 
much, really, doing different consents in one time. (FGD 4, Consent Counsellors) 
 
4.3.1.2 Implementing strategies to communicate information 
Representatives from all of these site constituencies described implementing certain practices 
to help communicate complicated information. CAB members and Educators reported 
implementing strategies to provide information to participating-community members and 
potential participants in a comprehensible manner. CAB members described translating terms 
in the informed consent using culturally-appropriate terms. Educators described that, by 
knowing terms commonly used in their respective communities, they were able to borrow 
these local, familiar phrases when explaining concepts (e.g. prevention or vaccine). For 
example, an Educator reportedly observed that in some communities people were not familiar 
with the word ‘vaccine’ but when the word vaccine has been phrased in their local language 
Xhosa (‘thintela gola’) people were able to understand the term. Educators reportedly made 
efforts to educate interested community members about key concepts by re-phrasing these in 
local familiar words - as exemplified in the following quote: 
There are people that they don’t know, what is the word vaccine (…) when you come with 
the word vaccine, they will start to be shocked, but when it comes to, you take the word 
vaccine and say it in Xhosa, then they will know okay. (FGD 3, Educators) 
 
Consent Counsellors described the importance of using simple (non-technical) language that 
retains the same meaning in order to enhance understanding among potential participants. 
Consent Counsellors and CAB members recognised the importance of ensuring that 
participants are comfortable with the language to be used to facilitate their understanding of 
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the study information, and described providing information using a preferred language. This 
reportedly made it easier to understand scientific concepts and encouraged interaction with 
the study team. Consent Counsellors also described switching between indigenous language 
and English to explain and address questions from potential participants (‘code-switching’). 
This reportedly made it easier for potential participants to understand more about research 
and procedures.  
Because as we can explain especially when it comes to Xhosa (…) you find that you get 
stuck, to explain in your own language. You know sometimes you would flip, you know, 
using English and then come back. (FGD 4, Consent Counsellors) 
 
It was stated that some concepts were best communicated using visual aids – or doing concrete 
tasks/ activities – Consent Counsellors reported that a number of topics which were difficult to 
comprehend were further explained in consent discussion groups through slide presentations, 
with pictures to reflect the concepts and procedures. It was reported that instruments (swabs, 
test tubes) were shown to increase understanding and trigger further discussion - illustrated in 
the following quote: 
… we again bridge that a little bit if we take the instruments, that we going to use. You bring 
it to them and we show them, pictures and this is what we going to do, this is how long it’s 
going to take, this is the swab that we going to use, so you make it more personal and then- 
we find that they feel they can discuss it more. Give it to them so they can hold it and, look 
at it and, so it’s not a faraway kind of procedure… (IDI 1, Site Staff)  
 
It was described that promoting discussion with participating community members and 
potential participants may help to promote understanding of difficult concepts. A number of 
strategies were reportedly used to promote interaction, such as conducting group-based 
educational events in the community and at the site, run by Educators, as well as conducting 
consent discussion groups at the site run by Consent Counsellors. It was reported that 
Educators would deliberately ask key questions in community locations to trigger debate and 
discussion between community members and site staff. It was also described that at these 
group events the asking of questions was expected, and encouraged and even modelled for 
attendees:  
…and also, and these you know we dealing with, nurses, we dealing with, teachers, 
people with, knowledge, you know they will want to know, if you know what you what 
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you are talking about. You know, by asking () a tricky question so, he or she want you to 
go deep, you know in whatever that you are, presenting. You know. (FGD 3, Educators) 
 
It seemed Consent Counsellors and Educators recognised the importance of repeating study 
information to participating community members and potential participants several times 
during the discussion or ongoing engagements. It was described that consideration was taken 
to ensure that difficult concepts have been revisited, for example ‘VISP’, to promote 
understanding. For example, IDI 1 Site Staff said: We know we can touch just on those difficult 
topics again.  
 
Educators and Consent Counsellors described that communicating concepts by using every-
day examples or common life experiences allow them to provide a clearer picture of HIV vaccine 
trials. It was reported that to ensure understanding of some concepts for example ‘partial 
efficacy’ site-staff made reference to every-day example of using ‘Panadol’ where it does not 
work 100% all of the time. It was further described that analogies were sometimes used (where 
one things stands in for another) to describe difficult concepts for example ‘the army’ to 
represent the immune system.  
 
Consent Counsellors and Educators understood that they had a great impact on imparting 
knowledge to potential participants and participating communities therefore took into 
consideration that building their own capacity to do so was crucial to ensure they are able to 
communicate complex information. It was reported that rehearsing and practising the content 
helped them get familiar with the study information:  
 
… I mean at the end of the day they do understand. It depends on how to explain it. You 
need to understand it yourself, before you go I mean, tell somebody else... (FGD 3, 
Educators) 
 
4.3.2 THEME 2 – EMOTIONAL ISSUES 
 
This theme sets out how CAB members, Educators and Consent Counsellors recognized the 
emotional concerns of participating-community members or potential participants, and how 




4.3.2.1 Recognizing emotional concerns 
Educators described that many communities’ members feel hopeless because they have 
witnessed the effects of HIV on their communities:  
… my role there is to help the community, in terms of first giving them the information, 
especially about the research the importance of doing the research because, I tell them 
that, if the, there is no research, happening, there will be no hope, at the end of the day 
that will get any, effective HIV vaccine that at the end of the day will help people who 
are HIV negative to be (.) protected against you know… (FGD 3, Educators) 
 
Educators and Consent Counsellors described concerns of potential participants and 
participating communities about perceived consequences of their involvement in HIV vaccine 
trials. Fear of harm from HIV research vaccine and experiencing side effects from receiving 
the vaccine was reportedly identified. Fears were aligned mainly to the side effects of the 
experimental vaccine; for example, in FGD 4, participants asked: Am I gonna get sick?. Fear of 
being infected by researchers with HIV was also described as a key concern, as illustrated in 
the following quote: 
 … sometimes when you speak about HIV vaccine, people they get scared you know, and 
then thinking that, ‘oh, I, am I not gonna get, HIV?’ You know ‘are they gonna infect me 
with HIV.’ Because you gonna get the HIV vaccine and then they think ‘oh maybe I will, I 
might be infected they might inject you, inject me with HIV’ … (FGD 3, Educators) 
 
It was also described that complexities of HIV vaccine trial concepts may trigger some 
uncertainty or anxiety in potential participants, hence the need to try to address uncertainties 
and promote understanding of concepts:  
 ‘It’s not a virus, and then it looks like a virus then why are you giving it to me? If it’s not a 
virus, am I gonna get sick? When will you give a participant a vaccine?’ (FGD 4, Consent 
Counsellors) 
 
Also, CAB members, Educators and Consent Counsellors encountered many suspicions from 
community members and potential participants about key aspects of the research, such as why 
the studies are being conducted in Africa, why the studies are being conducted at this 
particular site, why blood is withdrawn from study participants and even why it is flown outside 
the country. Their concerns include that countries and sites are chosen because of poverty and 
that participants are likely to be “used” in an unfair way to test products and that in 
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international trials blood will be sold to other countries. These concerns suggest that 
participating community members suspect that participating communities and even 
participants will be treated badly or unfairly for the benefit of the researchers. The following 
quote illustrates this point: 
…they’re very much aware of a guinea pig.  (…)So now to them, that’s what triggers them, 
that we making them guinea pigs. You see that’s other thing that now we need to unpack 
that no, we are not making you guinea pigs. (FDG 4, Consent Counsellors) 
 
It was reported that participating community members experience much suspicion about the 
site, the site-staff, the researchers, and even medical research in general. Even the CAB was 
sometimes viewed as ‘sell-outs’ or ‘brain-washed’ - and not trusted to represent the views and 
needs of the community. With regard to the site, it was described that participating 
community members see it as a place where people are damaged (‘we inject people, we kill 
people’ (FGD1). With regard to researchers, it was described they are seen as taking advantage 
of black communities due to poverty, lack of experience with research and devastation from 
HIV, and cannot be trusted to advance the interests of the community. This is exemplified in 
the following quote: 
So these white people they come with their thing, they wanted to infect us because, they 
know that we are desperate for money we are hungry we are not working. (FGD 3, 
Educators) 
 
It was also described that the site (research center) has a bad reputation from some community 
members who hold misconceptions about the site, for example, seeing it as a place where 
people get HIV-‘infected’.  
 
4.3.2.2 Addressing emotional concerns 
To respond to hopelessness, Educators reported providing information to participating 
communities and potential participant’s on the importance of, and the potential of, HIV 
vaccine research. Educators underscored the need to instill hope in participating communities 
and potential participant’s by describing responses to the epidemic, such as HIV treatment, 
and HIV prevention, and HIV prevention research. They described that education about HIV 
and HIV response efforts brought much renewed interest and inquiry about how people might 
become involved, and how their involvement may contribute to the common good. They 
reported community members asking the following:  
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‘Wow, this is amazing’ and then ‘when is it going to be, available.’ I mean especially for, for 
HIV (…) ‘where is for HIV? When is it going to be available?’  (FGD 3, Educators) 
 
To address suspicions, it was reported that inquiring about prior knowledge about HIV vaccines 
and research in general helped to uncover suspicions (myths) prevailing in the community 
about vaccine studies, and messages could be tailored to this existing information. This 
enabled Educators to better impart knowledge of research and vaccine research at education 
sessions in the community, or at the site. A number of strategies were reportedly used to 
identify existing knowledge, such as inquiring about rumours, or allowing potential 
participants to ask questions regarding the concepts which revealed their concerns. Much 
discussion then is centered on the misconceptions/ concerns to ensure that concerns have been 
addressed. Educators reported recording suspicions emanating from different communities.  
 
To address suspicions, it also was reported that utilizing past trial participants to share their 
experiences with potential participants was a useful approach. It is likely that this approach 
builds trust in the communicated information, because ex-participants have had direct 
experience of the study procedures. Educators also reported that different teaching methods 
would be employed by different past trial participants (e.g. drawing on the board, taking time 
to explain a concept, revealing their own life experiences). It was reported that past trial 
participants are from within the same communities and are reportedly able to address 
communities concerns based on their knowledge and experience of the trials. Educators 
reported that ‘bridging the gap’ between communities and the research team by using ex-trial 
participants brings more understanding of what participants ought to expect, teaches 
communities more about research and brings complex concepts close to people through 
discussion and interaction. It was reported that this helps in addressing people’s concerns, and 
addresses some of the misconceptions because some of ‘their’ members have lived through 
the experience of being part of the trial.  
 
Furthermore, it was also mentioned that site-staff utilize respected community sources to 
provide information about trials, which helps in ensuring that there is enhanced discussion 
between the research team and the community. It may serve to build confidence and develop 
trust when their own community leaders are aware of trials, and able to answer questions that 
community members have. Clarification of issues coming from the community and provision 




Also, Educators and Consent Counsellors reportedly referred to safe, effective vaccines which 
are close to people’s every-day experiences and which they may have encountered through 
the course of their lives - to address some of the concerns potential participants and 
community members have about vaccine trials. It was reported that some misconceptions 
about HIV vaccine trials (for example that people are deliberately harmed by injecting them 
with HIV) are well addressed if people are taught about the strict controls in vaccine research 
with humans. Educators and Consent counsellors promoted familiarization with new 
information about the trial vaccine by comparing it to proven vaccines already in existence, for 
example how vaccines protect from diseases e.g., polio vaccines which are used widely within 
the under-five population. This seemed to tap people’s experience of benefitting from this 
technology, and using it to promote the health of vulnerable and deserving groups such as 
children. This approach seemed to not only to promote comprehension but also appeared to 
instil trust among potential participants about medical research, and its contribution to 
society. As one remarked:  
You have to start with what they know. You have to start with the flu vaccine, why did they 
get the flu vaccine. Something that is similar to that () you have to explain, scientifically 
but, be more clear, by using practical examples. Something that they do on a daily basis... 
(FGD 4, Consent Counsellors) 
 
4.3.3 THEME 3 – RELATIONAL ISSUES 
 
This theme describes how key site stakeholders (CAB, Educators and Consent Counsellors) 
recognized cultural needs and preferences of community members and potential participants; 
and tried to interact with them in culturally respectful ways. Also, it describes how they tried 
to demonstrate respect more generally for participating-community members, and potential 
participants. 
 
4.3.3.1 Recognizing cultural norms 
It was reported that in the community, some people might act to please persons in authority 
and this meant that potential participants might report that they have comprehended 
information while they have not actually understood. Also, CAB members and Consent 
Counsellors recognized that there may be certain cultural beliefs and practices among 
potential participants and participating communities that may hinder discussion of key study 
information (both particular words and topics), and reported the need to ensure that - when 
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providing information – these factors are considered. They recognized the existence of cultural 
norms involved in talking about sex or sexual body parts. Consent counsellors reportedly 
observed that in the prevailing culture one should not discuss procedures involving sexual body 
parts (e.g. mucosal sampling, or circumcision of the male foreskin) with both women and men 
together. They reported that cultural norms also existed about what could be discussed 
between younger and older people. They noted that terms such as “anus”, “vagina” and “penis” 
when translated into local language are potentially disrespectful or offensive. CAB members 
and Consent Counsellors recognized the significance of cultural norms of participating-
community members and potential participants.  
… some of the wording, when you have to translate them in to Xhosa, in our African 
people, like if you say, to talk about, rectal, (sampling),(….)when you have to explain to 
them, it seems as if you being rude, you know because, (…)even at home, so when you 
have to talk about anus, and, vaginas, and now when you have to explain it in Xhosa, it’s 
becoming a big word and in her ears… (FGD, 4, Consent Counsellors)  
 
4.3.3.2 Responding to cultural complexities 
It was reported that CAB Members, Educators and Consent Counsellors are drawn from the 
same cultural backgrounds – which served to facilitate understanding of study information by 
using appropriate language and examples, as well as ensure knowledge of prevailing cultural 
norms. As one Consent Counsellor remarked: 
… because we live in the same community, with them, we know the challenges that they 
go through. So each and everything that they know, we do know so by making practical 
example when you going through a consent form (…) so if you living in this community, 
you gonna make example that do exist in this community… (FGD 4, Consent Counsellors) 
 
In response to the sensitive nature of certain words and topics, various strategies were 
reported in response. For example, Consent Counsellors reportedly made efforts to ‘inform’ 
potential participants about such information without being rude and disrespectful by 
requesting advance “permission” from potential participants to discuss sensitive issues with 
them and preparing them in advance to discuss a sensitive topic, as exemplified in the 
following quote: 
…it’s becoming a big word and in her ears. So you try to be like, even when you talk to her 
and say, “this is going to be sensitive. Now I’m going to explain what is going to happen 
to you. They are going to take this, and that, in this, and that” ( ….) so that she could 
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understand what is going to happen because they start to be shocked when you try to 
explain these words to them. So, at the same time, you as a counsellor you’re trying to 
make it easier for them so that they will know the procedures… (FGD 4, Consent 
Counsellors)  
 
It was described that individual sessions (after group sessions) were sometimes used, where 
more sensitive information could be discussed. It was also reported that appropriate language 
was used in discussing sensitive words or topics (e.g. for body parts). It was also reported that 
some concepts can be discussed in general when in a mixed group, but when detail is required 
then it recommended that groups be separated into male and female groups.  
…. so if its men and women that you recruit for a study, and you have them in one 
discussion group, you can’t really talk about circumcision. For example. Cos that, in the 
Xhosa culture is not something that gets discussed in front of women. So you have to be 
aware of that as well if there’s something specific around circumcision that needs to be 
discussed, then you have to separate the two groups, to be able to do that… (IDI 1 Site-
staff)  
 
Educators reported that, by knowing the cultural setting, they were able to provide messages 
to communities in a suitable and acceptable way. CAB members also reported the importance 
of making efforts to communicate with potential participants and participating communities 
using culturally-acceptable words. Also, to address the chance that people might respond to 
please persons in authority, Consent Counsellors reported asking potential participants to 
describe key concepts in their own words, rather than just rely on their self-reported 
understanding.  
 
CAB members and Educators reported encountering beliefs about the value and use of 
traditional medicine when interacting with participating community members. They reported 
that the health-seeking behaviours of community members is influenced by traditional 
practices. They drew from that experience to try to raise awareness about the contribution of 
‘western medicine’ to community health. They reportedly drew on their experience of common 
ailments, and commonly used medicines to clarify how research is conducted, and how 
medicines are developed. This is exemplified in the following quote: 
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Make them understand that these doctors, you can never be able to get your own (high) 
blood treatment without it being researched. Somebody risked his or her life (…) and then 
people start to melt down and understand that… (FGD 2, CAB Members) 
 
In addition to trying to show respect for particular cultural norms and language, these 
respondents also reported the importance of showing general respect for people. Showing 
general respect was conducted in different ways and also mattered with different audiences, 
namely, participating community members invited to sites for general discussions with 
educators and potential participants interacting with consent counsellors. CAB members 
noted the significance of being accommodating, being friendly, and offering refreshments, as 
narrated by one CAB member: 
Another thing to come to a research site, it’s most welcomed clinic, than in a public 
hospital. You will get, soft drink, and then you will be welcomed, and then you will be 
served, as early as, possible. (FGD 2, CAB Members) 
 
Educators identified that care should be taken to create an atmosphere for listening, learning 
and discussion of study information – where potential participants are put at ease – and this is 
achieved by treating people well. It was noted that potential participants bring misconceptions 
and fears but by allowing them to voice their concerns and listening them makes them feel 
respected. Educators recognized that the respect shown, and good hospitality provided, to 
potential participants might also encourage them to return to the site for more information.  
 
Consent Counsellors also noted the importance of treating potential participants well (e.g. 
greeting, making them comfortable, taking time to discuss information). Consent Counsellors 
further reported that ensuring that participants are encouraged to speak and ask questions 
also shows respect and enhances understanding of study information. They reported assuring 
potential participants about confidentiality - to ensure that participants were respected by 
keeping their personal information secure and confidential.  
Because it’s very important to understand the consent, so that they don’t consent on 
something that they don’t know. We give much detailed information on the nature of the 
study (…) And mostly, we include confidentiality because confidentiality is very most 
important, because, like for instance, like in (our files), we do have numbers instead of 
their names that includes confidentiality because when they take their bloods, no name 




In summary, this chapter has discussed the key findings of this study. It described how site 
stakeholders reportedly implemented different strategies that addressed relational, 









5.1  INTRODUCTION 
 
This chapter discusses the findings (3 major themes) set out in the previous chapter in terms of 
the existing literature relevant to informed consent, such as the literature related to 
community engagement, adult learning, health communication and empirical explorations of 
informed consent.  
 
5.2 THEME 1 – INFORMATIONAL ISSUES 
 
This section discusses the findings describing how site stakeholders (CAB members, Educators 
and Consent Counsellors) provided complex information to participating community members 
and potential participants by using various strategies. 
 
The findings show that CAB members, Educators and Consent Counsellors reported facing 
challenges with providing complicated information to participating communities and potential 
participants. Complex and complicated HIV vaccine trial terms were reportedly difficult to 
understand by both the site-stakeholders themselves and participating communities/potential 
participants, such as Vaccine Induced Seropositivity’. The complexity of HIV vaccine concepts 
has long been noted as a key challenge (Lindegger et al., 2006; UNAIDS, 2000). These site 
stakeholders recognized that difficulty in comprehending research concepts was partly 
attributable to little background or knowledge about trials or research in general, and little 
formal education - factors which have been noted by several commentators (Glickman et al., 
2009; Minnies et al., 2008; Ndebele et al., 2012). The findings also show that a lack of scientific 
terms in indigenous language (‘language barriers’) proved challenging to these stakeholders, 
which is in line with observations from several commentators (Kass & Hyder,2001; Marshall, 
2006;  Ndebele et al., 2012; Penn & Evans, 2009).  
 
Many of the practices reported here are consistent with recommendations from ethical 
guidelines to make efforts to disclose information in a way that is understandable (MRC, 2003; 
UNAIDS/AVAC GPP, 2011). For HIV prevention trials specifically guidelines (UNAIDS, 2012, 
UNAIDS/AVAC, 2011) recommend that researchers try to enhance comprehension of study 
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information using culturally acceptable strategies. Kass & Hyder (2001) have recommended 
that making use of indigenous-language speakers can ensure that the meanings of words are 
successfully conveyed to participating communities and potential research participants. 
 
Many of the strategies reported here resonate well with empirical research underscoring the 
significance of discussion in promoting comprehension of research (Flory & Emanuel, 2004), for 
example, where Educators reportedly make use of group-based educational sessions and 
Consent Counsellors reportedly make use of group-based consent discussion groups, where 
asking questions is encouraged. Furthermore, Consent Counsellors reported using a kind of 
“teach back” (where they ask potential participants to describe concepts in their own words) 
which has been recommended as a good way to recognise gaps in understanding so they can 
be addressed (Lindegger et al., 2006; Penn & Evans, 2009; Wade et al., 2009). It also supports 
the findings by Ndebele et al. (2014) that explaining concepts to others (part of the effective 
intervention) can facilitate understanding. Researchers should make efforts to assess prior 
knowledge of potential participants (Dunning, 2014). Efforts to promote discussion resonate 
with adult learning principles, where it is recognized that adult learners are not blank slates but 
have a rich bank of experiences to draw from (Nishimura et al, 2013; Sharma , 2006).  
 
Several commentators (Dickert & Sugarman, 2005; Fitzgerald et al., 2002; Rosenthal, 2006, as 
cited in Marshall, 2007; Preziosi et al., 1997; Wang et al., 2004; Woodsong & Karim, 2005) have 
also underscored the importance of discussion in enhancing comprehension – arguing that 
understanding is improved when research staff engage the potential participants/ participating 
communities in “active discussions” of the study and study procedures (Woodsong & Karim, 
2005, p. 414). Fitzgerald et al. (2002) reported that participants’ understanding of HIV vaccine 
concepts increased after discussions with a trained counsellor. Ndebele et al. (2012) found that 
an enriched consent process was associated with better understanding of HIV prevention trial 
concepts, and this included “asking participants to repeat in their own words or explain to 
others and inviting research participants to discuss with other potential or study participants” 
(p. 3). Promoting discussion of concepts may also help people make sense of ‘facts’ in a 
particular context – considered important in adult education (Meade, 1999). Promoting 
discussion might also help ensure that the implications of trial ‘facts’ are explored with 
potential participants so they are able to appreciate the ‘facts’ in terms of their daily lives 




In this study, Educators and Consent Counsellors reported using ‘aids’ to enhance 
understanding of research, particular studies and study procedures. Different strategies were 
reported (for example, making drawings on the board, using slides, showing blood tubes). 
Several of the techniques are in line with findings from other studies recommending aids, such 
as colourful pictures (Ndebele et al., 2012), and demonstrations of blood containers (Lally et 
al., 2014) to refute misunderstandings about “selling of the blood” (Stadler, 2010). To impart 
knowledge about new concepts, certain reported strategies resonated with principles of adult 
education and health communication (Knowles, 1980; Meade, 1999), for example, CAB 
members, Educators and Consent Counsellors all reported explaining research concepts by 
referring to common life experiences. This illustrates efforts to help potential participants and 
participating communities to understand novel research concepts by using familiar examples 
that clarify the research. This represented “efforts to help people understand new ideas by 
relating these to the rich reservoir of information and experience they already possess as adult 
learners” (Spezzini, 2010, as cited in Slack et al., 2016, p. 6) and helps make concepts 
meaningful (Ndebele et al., 2014). Educators reportedly used analogies to explain vaccines/ 
vaccine effects (e.g. the antibodies are like an ‘army’ that ‘fights’ intruders). Other 
commentators have pointed to the possible success of using of “analogies” in enhancing 
comprehension, noting that the strategy encourages the application of real life situations, or 
every-day scenarios to new ideas (Koblin et al., 2010). 
 
5.3 THEME 2 - EMOTIONAL ISSUES 
 
This section discusses the findings describing how site stakeholders (CAB members, 
Educators, and Consent Counsellors) recognized and attempted to respond to the emotional 
concerns of participating community members and potential participants, such as anxiety and 
mistrust.  
 
The findings show that potential participants and participating-community members 
reportedly experience some anxiety about the consequences of their involvement in HIV 
prevention research, namely being treated unfairly by the researchers or being harmed by the 
research. Complex HIV vaccine trial concept also reportedly triggered feelings of uncertainty 
in potential participants. Such feelings were reportedly recognized by both Educators and 
Consent Counsellors. Fears or concerns about harm were often aligned to the side effects of 
the experimental product (HIV vaccine). This suggests that helping people to understand 
research concepts should recognize fears and fearful beliefs that may have been derived from 
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lay information sources (Charles et al., 1999; White et al., 2003). Anxiety has been identified as 
an important emotion in decision-making because it may interfere with the processing of 
information (Lindegger & Richter, 2000). 
 
The findings also show that participating community members experience considerable 
mistrust about the site itself, the site-staff, and the research procedures (such as blood draws). 
This mistrust was reportedly recognized by both Educators and Consent Counsellors. This is in 
line with previous studies, such as Stadler and Saithre (2010) who described much suspicion in 
participating communities/ potential participants about HIV prevention trials, including about 
blood being sold for profit. Andrasik et al. (2014) also found considerable suspicion about 
researchers, research procedures, and experimental HIV prevention products in participating 
community members, including that vaccines might cause HIV infection.  
 
Barsdorf and Wassenaar (2005) investigated racial differences in perceived voluntariness of 
research participants in South Africa following Apartheid, characterised by systematic 
violation of the human rights of black South Africans. They highlighted how black South 
Africans may be apprehensive of scientific research in which black South Africans are perceived 
to be targeted for participation, irrespective of a sound purpose for involving them. They 
further stipulated that these potential abuses underpin and ground mistrust of medical 
research. 
 
To respond to mistrust or suspicion, Educators and Consent Counsellors reportedly inquired 
about and collated information about participating communities’ suspicions - representing 
efforts to identify existing knowledge and to uncover suspicions emanating from participating 
communities about vaccine studies. Kamuya, Theobald, Marsh and Parker (2015) reported 
exploring myths about involvement in vaccine studies in Kenya and noted this was helpful in 
provision of reassurance and clarifying misinformation. In this study, this practice of keeping 
records of rumours emanating from communities allowed educators to explicitly tailor their 
informational messages (cf. Woodsong & Karim, 2005). This practice resonates well with 
recommendations from Lally et al. (2014) to explicitly refer to and refute misconceptions in 
order to improve understanding but may go further insofar as this strategy might also decrease 




Also, the approach of utilizing ex-participants to provide educational information about study 
related activities, concepts and research in general was reportedly used. Furthermore, it was 
noted that influential figures in the community are commonly engaged by educational efforts. 
The importance of reaching out to recognized community leaders and representatives is 
underscored by several commentators (Kamuya, 2015; Ndebele et al., 2012; Rubincam, 
Lacombe-Duncan & Newman 2016; Woodsong & Karim, 2005) and making use of such 
‘trustworthy’ sources may represent efforts to increase the credibility of information about the 
site and the research. Ethical guidelines also recommend that trials engage with respected 
community figures (UNAIDS/AVAC, 2011). The findings underscore the significance of 
researchers “creating the conditions for trust” in the communities where they are conducting 
research, making efforts to respect cultural or social needs of participants, building 
relationships, and “establishing rapport” (Guillemin et al., 2016, p. 5). 
 
To respond to feelings of mistrust and even anxiety about research procedures and about 
vaccines, it was reported by both Educators and Consent Counsellors that they refer to safe, 
licenced vaccines. This served to highlight the rigor of the vaccine development process, and 
to invoke the contribution of vaccines to human health. This resonates with principles of adult 
learning and health communication which stipulate that prior knowledge is critical when 
constructing new knowledge (Popkewitz et al., 2001, as cited in Martin, 2006); that individual’s 
previous experience help them establish a basis to advance their knowledge (Meade, 1999) and 
where comprehension of key concepts will depend on existing frames of reference (Martin, 
2006). In addition, Consent Counsellors described several practices to try to set potential 
participants at ease (described in the results section under theme 3), namely to greet them, to 
use humour, to offer refreshments and other practices that might have the effect of lessening 
anxiety. Lindegger and Richter (2000, p. 3) asserted the following:  
… emotional factors are likely to impact substantially on the research participants’ ability 
to evaluate the information given to them. Anxiety arising from an excess of information 
or apprehension of risk is an example of emotional factors likely to affect understanding. 
 
Overall, several of the practices described under this theme resonate with an important model 
recommended for use in consent-related interactions (the ‘Meerwein model’) – insofar as one 
aspect of the model is concerned with the capacity and willingness of research staff to perceive 
and discuss emotional needs, concerns and complaints of potential participants and to address 
these  (Ndebele et al., 2012 ;Tomamichel et al.,1995). Several practices resonate with 
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recommendations in a key article arguing for sound consent communication, for example, 
Meade (1999) noted that addressing anxiety may help potential participants to engage in 
problem-solving and to make decisions in consent-related encounters.  
 
5.4 THEME 3 – RELATIONAL ISSUES 
 
Strategies to acknowledge the cultural norms of participating-community members and 
potential participants were reportedly engaged in by all constituencies (CAB Members, 
Educators and Consent Counsellors), such as using culturally acceptable terms. This reflects 
efforts to be sensitive to the language prevailing in the participating community and to use 
appropriate linguistic terms and match linguistic preferences (Lindegger & Richter, 2000).  
 
In this study it was reported that CAB members, Educators and Consent Counsellors have 
many attributes that match those of the participating community (e.g. language, culture, 
traditions) and are familiar with terms and ideas commonly invoked in the participating 
community. For research generally, several commentators (Dickert & Sugarman, 2005, as cited 
in Marshall, 2007; Marshall & Rotimi, 2001; Strauss et al., 2001) reported that comprehension 
of study terms can be enhanced through making use of (or consulting) with “cultural experts” 
to ensure effective ways of communicating with potential research participants, and it is likely 
that the site-stakeholders in this study contribute their cultural expertise to the task of 
explaining difficult concepts (Sibbald et al., 2015, p. 2). ‘Matching’ cultural, racial and linguistic 
backgrounds might set the stage for improved understanding of information by using 
appropriate language and every-day examples, but might also ensure that interactions are 
sensitive to and respectful of cultural preferences.  
 
It has been noted that being knowledgeable about culture can enhance effective 
communication (Buchwald et al., 1994; Campinha-Bacote, 1995). Chatalalsingh (2013) stated 
that “cultural competence” (p. 5) allows research teams to communicate respectfully across 
cultures and understand local perceptions of health, disease and illness. The stakeholders in 
this study reportedly recognised that health-seeking behaviours of community members are 
influenced by traditional practices and drew from that experience to try to raise awareness 
about the contribution of ‘western medicine’ to their every-day lives. They reportedly drew on 
community experience of common ailments, and common medicines to clarify how research 
is conducted to develop medical products that are popular, helpful and ingrained in community 
life. Lindegger and Richter (2000) also highlighted that research teams members with ‘cultural 
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competence’ should give information to potential participants because they have a deeper 
understanding on how to frame the material.  
 
Consent Counsellors recognized there may be certain cultural beliefs and practices among 
potential participants and participating communities that may hinder discussion of critical 
study information (such as mucosal sampling), and educators reported the same in discussions 
about safer sex practices and prevention modalities such as male circumcision. These 
stakeholders found ways to ensure that such information was in fact discussed which suggests 
they did not uncritically accept cultural norms about not discussing culturally ‘taboo’ topics 
(Bayer, 1994, as cited in Slack et al., 2016). For example, Consent counsellors reported that in 
order to inform potential participants about some of the trial procedures i.e mucosal sampling 
(which is a difficult topic to be discussed by female counsellors to male participants or vice 
versa) they reportedly ‘prepared the ground’ for exposure to sensitive information. This 
suggests that they did not necessarily view cultural norms as ‘trumping’ the critical importance 
of comprehending key study-related information (cf. Lindegger & Richter, 2000; Slack et al., 
2016). 
 
In addition to trying to show cultural respect, these constituencies described the importance 
of demonstrating general respect for persons. That is, Educators and Consent counsellors 
described the importance of being accommodating and being friendly to persons who visit the 
site expressing interest in the research (e.g. greeting, offering refreshments). Consent 
counsellors underscored the importance of showing general respect for each person over and 
above their value as a trial participant, and creating an environment conducive to building 
interpersonal rapport and to discussion of study information. Good participatory practice 
guidelines (UNAIDS/AVAC GPP, 2011) recommend that participating community members be 
respectfully engaged by site-staff to build the foundation necessary for these complex studies 
to be implemented. Eraut (2004) has highlighted the need to establish relationships before 
engagement in discussions of sensitive or personal material, to enable persons to disclose their 
concerns. Consent Counsellors also reported assuring potential participants about 
confidentiality which are consistent with ethical guideline recommendations to manage 
sensitive information appropriately (MRC, 2003; UNAIDS/AVAC 2011; UNAIDS 2012). 
 
In summary, this chapter has examined the study’s main findings in relation to the existing 
literature relevant to informed consent, such as the literature related to community 
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CONCLUSION AND RECOMMENDATIONS 
 
6.1  INTRODUCTION 
 
This study aimed to explore practices reportedly used to communicate complex concepts in 
HVTs. The key objectives were firstly, to explore strategies reported by key stakeholders in 
South African HVTs to communicate trial information; secondly, to explore the 
correspondence of reported strategies with recommended practices from the conceptual and 
empirical literature; and thirdly, to explore the implications for strengthening the informed 
consent process in resource-constrained settings. This chapter sets out some concluding 





6.2.1 STRATEGIES TO COMMUNICATE TRIAL INFORMATION 
 
In terms of the first aim, this study concludes that site stakeholders (CABs, Educators and 
Consent Counsellors) reportedly employed various practices to explain complex trial 
information. These constituents reportedly employed numerous strategies to ensure that 
information presented to potential participants was clear, and linked to their day-to-day 
experiences. These included translating terms in the informed consent using local language, 
using simple (non-technical) language, and using preferred language familiar to participating 
communities and potential participants, to enable comprehension. Information was presented 
according to or tailored to literacy levels and other factors of groups. Teaching aids - which 
comprised presentations, pictorial representations, instruments and demonstrations - were 
reportedly used to try to address misunderstandings. Study constituents underscored the 
importance of creating interactive sessions, by encouraging and promoting discussion with 
different groups of potential participants, and with consideration of group dynamics, and 
linguistic needs (cf. Meade, 1999). The study further concludes that site-staff were 
instrumental in trying to provide consistent, relevant and correct information to potential 
participant’s in order to enhance comprehension. Strategies to ensure that staff remain 
motivated and informed on how best to impart knowledge included ‘rehearsals’ with, and feed-
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back from, site staff to build their skills in presentations, and to build their confidence to share 
information with a diverse population. However, further investigation is required to learn how 
practices of site staff actually impact these sessions, which is addressed in the final section of 
this chapter. 
 
This study also concludes that – in addition to practices employed to improve understanding – 
these site stakeholders also appear committed to attending to the emotional aspects, and to 
interacting in a culturally respectful way. Some of the strategies reported here indicate the 
goals site staff had not only towards enhancing comprehension of complex concepts, but also 
towards respecting emotions and respecting culture of potential participants. That is, they 
reported strategies that show they are not just focussed on the information but try to respect 
feelings and to respond to cultural norms. That is they appear to have more than one goal in 
mind (cf. Slack et al., 2016). 
 
6.2.2 CORRESPONDENCE OF STRATEGIES WITH RECOMMENDED PRACTICES 
 
In terms of the second aim, this study concludes that many of the strategies reportedly 
implemented to enhance understanding expressed by the different constituents are consistent 
with recommendations from key literature and ethical guidelines. That is, the strategies 
reportedly employed to communicate complex information correspond with certain key 
principles of adult education and communication. More specifically, that prior knowledge or 
experience is critical when constructing new knowledge, which was realised in the study by 
exploring prior knowledge and experiences of potential participants. Also, that learning 
encounters for adult learners should employ interactive activities and processes which were 
reported as being achieved by engaging potential participants/ participating communities in 
educational encounters, where discussions, questions-and-answers sessions, and presentation 
of various aids took place. Also, that learning needs of adult learners should be explored which 
was realised by exploring the needs, and concerns of potential participants/ participating 
communities through inquiring, and compiling a list of rumours, myths and misconceptions to 
help site staff develop messages to refute them. Finally, by ensuring that existing frames of 
reference should be used to enhance understanding of new complex concepts which was 
realised by use of every-day life examples and familiar experiences in their daily lives (Charles 




The study concludes that site-staff appear committed to building trust and sound relationships 
between site staff and participating communities or study participants – which corresponds 
well with recommendations from ethical guidelines (UNAIDS/AVAC GPP, 2011).  The 
strategies implemented to build confidence, and develop trust, included: utilising respected 
community sources to provide information about trials (engaging community members who 
hold various power structures within communities), use of community representatives familiar 
with the cultural, linguistic and social needs of potential participants as reported by the use of 
ex-trial participants as reported in the study and making reference to existing health 
programmes and already licensed vaccines widely used within communities locally. Ethical 
guidelines do not necessarily spell out the precise practices that sites should implement to 
build trust, but rather underscore the central importance of building trusting relationships with 
participating-community members. 
 
The study concludes that several strategies are implemented to try respond to emotions of 
anxiety and to try to address feelings of suspicion, as well as to develop respectful relationships 
(by creating a friendly environment) that are responsive to cultural norms. The study concludes 
that efforts by the study constituents to address emotions are consistent with aspects of a 
useful model of the informing process - the Meerwein model – that is, to perceive and respond 
to emotions (cf. Ndebele et al., 2014; Tomamichel et al., 1995). The declared practices included 
exploring their existing knowledge, concerns and fears (with no reports of criticizing them 
about what they believe about vaccine trials and research in general although social desirability 
may have prevented such reports). Site stakeholders seemed committed to creating a 
conducive environment where participating community members and potential participants 
felt at ease, and were recognised and respected, and to conducting discussion sessions with 
consideration of cultural norms existing in the communities.  
 
6.2.3 IMPLICATIONS FOR CONSENT PROCESSES IN RESOURCE LIMITED SETTINGS 
 
In terms of the third aim, the study findings have several implications for research conducted 
in low-resource settings. This site is implementing an approach where dedicated staff convey 
complicated information at various stages – by Educators out in the community, by Educators 
at the site, and by Consent Counsellors at the site holding group discussions. This approach is 
likely to be expensive (in terms of salaries and training for staff). This implies that researchers 
need to ensure such approaches are funded, and are included in line items of budgets, and it is 




This approach also means that CAB members and site staff will be sharing information about 
the same key aspects of the trial, and that potential participants might hear information from 
more than one stakeholder. This implies that there could be the chance that the same 
information is explained differently by different stakeholders (even though this problem was 
not explicitly reported in this study) – which could lead to misunderstandings or suspicion or 
rumors where participants/ participating communities try to fill gaps in understanding (Marsh 
et al., 2010). This implies that all the groups involved in communicating key information may 
need some training on how to communicate ideas consistently and such training will also 
require resources. Training on communication aspects may require that researchers 
conducting research in low-resource settings partner with communication experts at local 
universities- to equip them with communication skills, which may be fairly inexpensive. This 
entails that funding for research in LRS take into consideration communication needs of 
research staff in order to build their communication competencies. . 
 
This site is also implementing an approach where community representatives, ex-trial 
participants and CAB members are utilised to convey complicated information about study 
activities - to address misconceptions, fears, concerns and myths. This approach will require 
careful scrutiny and evaluation to ensure that the content being presented is relevant and 
consistent. Such evaluations will also take resources, and may have to be designed in a way 
that minimizes resource-use. To reduce costs of evaluations, site staff could develop standard 
materials to be used by community representatives when they are providing education to 
ensure consistency of messages. Site staff could hold educational inspections or observation 
where they can shadow community representative’s education efforts to assess 
communication skills and information content. To help them to strengthen skills and assess 
how they present information site staff could conduct rehearsal sessions to help community 
representatives show- case their skills before they engage with fellow community members. 
 
The study found that rumours, myths, misconceptions, fear and concerns are explored by site 
stakeholders – these ‘myths’ could inform how to develop recruitment and education tools (for 
example brochures), how to frame messages and how to engage communities. This might be 




These findings suggest that the individual consent process is best understood as preceded by 
a larger process of engagement (UNAIDS/AVAC GPP, 2011; Marsh et al., 2010; Strauss et al., 
2001). That is, people presenting for consent for trial enrolment might well have been exposed 
to prior information in the community (Woodsong & Karim, 2005) so it would be best if that 
prior information in the community was accurate and consistent with information given in the 
individual informed consent. This implies that development of key messages for the individual 
consent needs to consider these lay understandings and beliefs. This implies that Educators 
interacting with participating community members should appraise Consent Counsellors 
interacting with potential participants – which could be done at little additional cost to the 
research team.  
 
The approach of employing various stakeholders to help communicate complex concepts 
remains critical. However issues of power relations between site staff and potential 
participants, and social desirability concerns reported in guidelines (MRC, 2003) and empirical 
research (Lindegger et al., 2006) require further investigation in order to evaluate those 
strategies which actually enhance understanding of complex concepts ‘on the ground’ in real 
settings – which would offset a weakness of this study’s reliance on reported strategies and 
their perceived impact on understanding.  
 
This site is implementing an approach where site staff report the importance of ‘cultural 
competence’ - by using culturally acceptable terms, by coming from the same cultural, racial 
and linguistic backgrounds, by using appropriate language and every-day life experiences, by 
understanding local perspectives of health, disease and illness, and by respecting and 
recognizing cultural norms which may impact education and consent exchanges. This implies 
that site staff should have the ability to engage participants/ participating communities with 
diverse beliefs, norms, behaviours and values; and informing procedures should be tailored to 
suit cultural, racial, social and linguistic backgrounds. This implies that sensitivity is needed 
when recruiting and hiring such staff. 
 
This approach means that site staff needs to be culturally competent by having the skills to 
manage their own preconceptions, to discuss study information respectfully and sensitively 
and to respect peoples own values and experiences. This means sites are responsible for having 
adequate understanding of relevant local communities (culturally and socially). However, 
Marshall et al. (2011) have noted the challenges in understanding cultural context as these are 
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not socially, geographically or historically static, and have articulated that culture is porous and 
dynamic and responsive to social and political realities. 
 
Another implication lies in resource mobilization. To mobilise communities to engage in 
development of consent processes, and to work with communities to develop locally relevant 
research terms requires time, resources and the need to draw from expertise within 
communities from different areas. This may not be realised in resource-constrained settings 
due to lack of resources and capacity and commitment of staff, however, each site could 
develop good working practices and standard operating procedures, and could collect 




In this section, recommendations are made for various groups, including researchers and 
research staff, ethics committee members, participating community members and finally for 
developers of ethical guidelines. 
 
6.3.1 FOR RESEARCHERS AND STAFF AT SITES 
 
There is a need to continue to equip those involved in informed consent and educational 
sessions with potential participants or participating community members with communication 
competencies to help them to convey trial information. This could be done by ongoing training 
for Consent Counsellors, Educators and site staff explicitly on good communication skills 
(especially those not reported here) such as gauging participants formal and informal verbal 
communication signs (cf. Meade, 1999).  
 
However, in addition, there should be more explicit acknowledgement of how site 
constituencies try to handle different emotions expressed by participants or participating 
community members such as suspicion (this seems a somewhat under-recognized task) 
(Rautenbach et al., 2015), and they should be asked about the kind of support they need to 
manage this task. Also, it is essential that sites themselves try to evaluate how well site staff 
are ‘educating’ potential participants, including communication competencies and content 
delivery or development, including message consistency. There is need for ongoing 





Because of the need for site staff to be ‘culturally competent’, decisions have to be made on a 
protocol basis about which site staff should engage with communities/ participants taking into 
consideration their cultural, linguistic and social expertise. Site staff views should be canvassed 
on how to develop cultural competencies to enable them engage with culturally diverse 
populations. There is a need for ongoing development of messages which will help refute 
misunderstandings, myths and misconceptions to ensure effective communication. Site staff 
need to develop and frame messages to address emotional aspects within their participating 
communities.  
 
Site staff need to evaluate engagement strategies that are effective in offsetting myths, 
misconceptions. Site staff need to collect data on where rumours are coming from, why there 
are rumours, the patterns of rumours and what they signify – to help them plan their 
educational sessions and to develop message- content.  
 
6.3.2 FOR RECS 
 
The review of informed consent by RECs should not only entail ensuring that researchers have 
stipulated important information in the consent forms but rather reflect on strategies and 
processes of how informed consent will be achieved (cf. Slack et al., 2016). This reflexive 
approach will help researchers reflect on good informed consent practices and remain 
accountable to achieving them during the conduct of the study. Also, RECs should employ 
mechanisms to collect feedback from researchers about challenges with informed consent in 
their studies. Getting feedback from researchers may help assess whether the team is 
conducting the process as stipulated in the protocol. Feedback may be a great chance for the 
REC to develop good practices and recommend their adoption in studies with similar context. 
Furthermore, continued monitoring of approved studies can be implemented by RECs to 
observe, inspect environments where informed consent procedures are conducted, and assess 
how site staff implement conduct informed consent procedures. Lastly, RECs should review 







6.3.3 FOR CAB MEMBERS 
 
The findings of the study indicate that CAB members encountered many suspicions from 
community members and potential participants about key aspects of the study. The findings 
highlighted by CAB member on the need to address participants’ emotions of mistrust suggest 
CAB members may need ongoing support. The findings indicate some of the challenges 
experienced by CAB members in conveying complex concepts to participating-community are 
due to lack of formal education, lack of terms in local language and complex concepts. CAB 
members need to request materials to ensure consistency of terms. There is also a need to 
develop a curriculum for those who engage with communities informed by principles of 
communication and education, and key dimensions of the informing process. Also, there is 
need to scrutinize the selection process of CAB members, taking into consideration formal 
education level which may have an impact on understanding of research and complex concepts 
in general. It may also help to observe CAB members in the field as they educate the 
community, and evaluate their approach. Additional research is required on how CAB can 
enhance their relationship with community members and also act as independent entities.  
 
6.3.4 FOR ETHICAL-GUIDELINE DEVELOPERS 
 
Developers of ethical guidelines should ensure that guidelines focus on process aspects of 
consent. For example, the Malawian national guidelines do not consider explicitly some of the 
challenges inherent in enrolling participants in complex trials - for example low literacy, 
complex medical terminologies, low research literacy (Lindegger et al., 2007; Stuurman, 2004; 
Watermeyer & Penn, 2008). Also, they do not focus much on the need for communication, and 
“cultural competence” of site staff (Buchwald et al., 1994; Chatalalsingh, 2013; Campinha-
Bacote, 1995; Kaufert & Putsch, 1997).  
 
6.3.5 FOR DEVELOPERS OF MODELS 
 
It is important for developers of conceptual models of the ‘informing process’ (such as the 
Meerwein model) to consider much more explicitly, and much fully, the role of trust and 
mistrust in this process. The findings here suggest that perceived credibility of information 
played a crucial role in how information was received, and also that strategies to ensure 
credibility were challenging. Mistrust was found to be a challenge between site staff and 
participating communities or study participants, yet there is not yet detailed consideration 
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in the Meerwein model about how trust might impacts comprehension of new information. 
Developers of conceptual models need to consider how issues of trust or mistrust could be 
more fully addressed.  
 
6.3.6 FOR FUTURE RESEARCHERS 
 
It is crucial for future research to record, observe and analyse actual consent encounters and 
engagement encounters in HIV vaccine trials (procedure of observation of sessions), because this 
may help open an important “black box” of the actual practices implemented on the ground 
instead of relying on self-reported strategies for communicating complex information (Wade 
et al., 1999, as cited in Slack et al., 2016, p. 9). It may help to use the self-reported strategies in 
this study to develop an observational tool to evaluate how well concepts are communicated, 
how well negative feelings are addressed, and how well cultural aspects are addressed.  
 
There is still a gap regarding the evaluation of how ethical guidelines for informed consent are 
actually implemented in resource-constrained settings. There is need for more empirical 
research to identify strategies that enhance comprehension especially in trials which has 
complex concepts. This may identify which interpersonal processes are effective in promoting 
understanding of complex HIV concepts, or even in increasing trust.  
 
Participants enrolled in HIV vaccine trials need to be involved in future research in order to shed 
light how interactions with site staff are experienced, and what practices they find applicable 
to enhance their understanding of complex concepts. There is need to allow participants to 
report their preferred strategies which enhance comprehension, what kind of interpersonal 
interactions are believed to influence their understanding, to offset power relations between 
them and study staff, and to build trust.  
 
Site staff and community representatives are engaged in “informing” potential participants 
however, little is known about how power relations between these entities impact on this 
process. Trust building has been one issue reported in the study, and there is need to further 
investigate how building trust might impact power relations, or how participants learn new 
information or how they make decisions to take part.  
 
It was reported in the study that community representatives encountered many suspicions 
from their fellow community members. There is need to explore the roles of CAB and how they 
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can best maintain their trusted role of representing community members. Lastly, this study 
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